<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2023.1203550</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sujarwoto</surname>
<given-names>Sujarwoto</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1687172/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maharani</surname>
<given-names>Asri</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1974982/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Public Administration, Faculty of Administrative Science, Brawijaya University</institution>, <addr-line>Malang</addr-line>, <country>Indonesia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Nursing, Faculty of Health and Education, Manchester Metropolitan University</institution>, <addr-line>Manchester</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by">
<p>Edited by: Sara Manti, University of Messina, Italy</p>
</fn>
<fn id="fn0002" fn-type="edited-by">
<p>Reviewed by: Pasquale Stefanizzi, University of Bari Aldo Moro, Italy; Siyu Chen, The Chinese University of Hong Kong, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Sujarwoto Sujarwoto, <email>sujarwoto@ub.ac.id</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1203550</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Sujarwoto and Maharani.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Sujarwoto and Maharani</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Lack of knowledge regarding the coronavirus disease (COVID-19) and COVID-19 vaccines is a key barrier to COVID-19 vaccine uptake in low- and middle-income countries (LMICs).</p>
</sec>
<sec>
<title>Aims</title>
<p>To examine factors associated with knowledge about COVID-19 and the association between knowledge of COVID-19, willingness to receive a COVID-19 vaccine, and vaccine uptake in Malang, East Java, Indonesia.</p>
</sec>
<sec>
<title>Method</title>
<p>A cross-sectional study among individuals aged 15&#x2013;99 years was conducted in Malang, Java Timur, Indonesia between November 2022 and January 2023. Of 10,050 potential respondents, 10,007 were able to complete the survey. The main independent variable was knowledge about COVID-19, which was assessed using a six-item questionnaire. The dependent variables were COVID-19 vaccine uptake and COVID-19 booster vaccine uptake. The mediating variable was respondent&#x2019;s willingness to receive a COVID-19 vaccine. Linear regression was used to examine factors associated with knowledge about COVID-19. Logistic regression was employed to examine the association of knowledge about COVID-19 with vaccine uptake. Generalized structural equation modeling (GSEM) was performed to examine whether willingness to receive a vaccine mediated the association between knowledge about COVID-19 and vaccination uptake.</p>
</sec>
<sec>
<title>Findings</title>
<p>The percentage of respondents who reported having received at least one dose of a COVID-19 vaccine was 94.8%, while the percentage of those who reported having received at least three doses was 88.5%. These numbers are higher than the national average for COVID-19 vaccine and booster vaccine uptake. Most respondents answered about four of six knowledge items correctly (<italic>M</italic>&#x2009;=&#x2009;4.60, SD&#x2009;=&#x2009;1.1). Among respondents who had not received a vaccine, 83.1% expressed willingness to receive a vaccine when it became available to them. Older, more educated, employed respondents, and those with higher economic status, demonstrated more accurate knowledge about COVID-19 than younger, less educated, unemployed respondents and those with lower economic status. Respondents who demonstrated more accurate knowledge about COVID-19 were more likely to have received a vaccine (OR&#x2009;=&#x2009;1.528, 95% CI&#x2009;=&#x2009;1.428&#x2013;1.634) and a booster vaccine (OR&#x2009;=&#x2009;1.260, 95% CI&#x2009;=&#x2009;1.196&#x2013;1.328). Willingness to receive a vaccine mediated the association between knowledge about COVID-19 and vaccine uptake (coef. = 0.426, 95% CI&#x2009;=&#x2009;0.379&#x2013;0.473).</p>
</sec>
<sec>
<title>Implications</title>
<p>Interventions and public health programs aiming to improve knowledge about COVID-19 can be implemented to improve individual willingness to receive COVID-19 vaccination and to improve COVID-19 vaccine uptake among the general population.</p>
</sec>
</abstract>
<kwd-group>
<kwd>COVID-19 knowledge</kwd>
<kwd>willingness to receive vaccine</kwd>
<kwd>vaccine uptake</kwd>
<kwd>vaccine booster uptake</kwd>
<kwd>vaccine hesitancy</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="61"/>
<page-count count="12"/>
<word-count count="9044"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Diseases: Epidemiology and Prevention</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="sec6" sec-type="intro">
<title>1. Introduction</title>
<p>COVID-19 vaccine hesitancy is one of the major barriers to vaccine uptake worldwide (<xref ref-type="bibr" rid="ref1">1</xref>). This barrier is often associated with a lack of knowledge regarding COVID-19 and COVID-19 vaccines within the general population. It is well documented that lack of knowledge regarding COVID-19 vaccines, vaccination schedules, location of vaccination centers, and vaccine effectiveness leads to lower vaccine uptake (<xref ref-type="bibr" rid="ref2">2</xref>). One study also reported that more accurate knowledge about COVID-19 vaccines is associated with lower levels of hesitancy and higher levels of vaccination acceptance (<xref ref-type="bibr" rid="ref1">1</xref>). In contrast, less accurate knowledge and misinformation regarding COVID-19 vaccines are the main drivers of vaccine hesitancy (<xref ref-type="bibr" rid="ref3">3</xref>).</p>
<p>While studies examining the role of knowledge regarding COVID-19 vaccines in vaccine hesitancy have been widely conducted, the number of studies considering the link between knowledge about COVID-19 and vaccine uptake and booster vaccine uptake remains limited (<xref ref-type="bibr" rid="ref4">4</xref>). The literature on health literacy highlights that health knowledge constitutes a background factor that promotes health prevention activities, including vaccination uptake (<xref ref-type="bibr" rid="ref5">5</xref>). This concept is supported by a study that suggests that knowledge supports effective health-related decision-making (<xref ref-type="bibr" rid="ref6">6</xref>). People with more knowledge about health risks, signs and symptoms, and the benefits of preventive actions tend to have healthier lifestyles (<xref ref-type="bibr" rid="ref7">7</xref>). A higher level of health knowledge is also associated with less difficulty in navigating the health care system, greater access to health care, and more effective utilization of health resources for disease prevention (<xref ref-type="bibr" rid="ref8">8</xref>). This concept is consistent with the expression &#x201C;knowledge is power,&#x201D; which has appeared in cognitive science for decades to illustrate the importance of knowledge in human and artificial intelligence (<xref ref-type="bibr" rid="ref9">9</xref>). Theories such as the long-term working memory theory propose that the advantages conferred by knowledge are due to knowledge structures that facilitate comprehension of and memory for information that is germane to the knowledge domain (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>Moreover, studies on communicable diseases have shown that knowledge about a disease is an important predictor of behaviors that impact the spread of the disease (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref10">10</xref>). For example, prior knowledge about a disease has been shown to encourage protective behaviors such as increased handwashing and increased willingness to forgo public activities (<xref ref-type="bibr" rid="ref10">10</xref>). Misunderstanding or knowledge deficit regarding influenza has also been shown to reduce the adoption of protective behaviors (<xref ref-type="bibr" rid="ref11">11</xref>). However, a recent study on COVID-19 reported no effects of knowledge on protective behavior (<xref ref-type="bibr" rid="ref12">12</xref>). Another study, conducted when physical distancing but not mask-wearing was highly recommended (<xref ref-type="bibr" rid="ref13">13</xref>), found that higher levels of COVID-19 knowledge were associated with attending fewer large gatherings but not with wearing a mask when leaving home (<xref ref-type="bibr" rid="ref14">14</xref>). These mixed findings indicate a need for further investigation in various health system contexts, especially in LMICs, where knowledge sources regarding diseases are limited, low uptake of vaccination often occurs, and most people are less educated and less willing to accept vaccines (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>Individuals with chronic disease, including cardiovascular disease and chronic obstructive pulmonary disease, are among the target of COVID-19 vaccination strategies because they are more likely to have the SARS-Cov-2 infection, and once infected, they are at higher risks of developing serious complications that can lead to mortality (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref18">18</xref>). Mohseni et al. found that influenza vaccination among patients with heart failure was associated with a lower risk of hospitalization in England (<xref ref-type="bibr" rid="ref19">19</xref>). However, the coverage of individuals with chronic disease is more likely to be lower. For example, a study in Italy showed that only 22.8 and 7.2% of patients with chronic diseases and hospitalized due to those conditions received influenza and pneumococcal vaccines, respectively (<xref ref-type="bibr" rid="ref20">20</xref>, <xref ref-type="bibr" rid="ref21">21</xref>). A meta-analysis study including data from 31 studies from countries found that the pooled acceptance rate of COVID-19 vaccine among patients with chronic diseases is 65% (<xref ref-type="bibr" rid="ref22">22</xref>), which is still below the target (75&#x2013;90%). Improving the vaccine acceptance of patients with chronic diseases is thus important to reduce hospitalization and mortality.</p>
<p>The case of Indonesia is interesting to examine the role of general population knowledge about COVID-19 in vaccination uptake and booster vaccination uptake. The country has faced some difficult COVID-19 surges, with more than 6.41 million COVID-19 cases and 157,844 deaths as of September 2022, making vaccination uptake crucial to reduce morbidity and mortality. By March 18, 2023, the proportion of the Indonesian population having received at least one dose of COVID-19 vaccine rose to 86% and those with at least three doses comprised 37% of the population (<xref ref-type="bibr" rid="ref23">23</xref>). Moreover, the percentage of vaccination uptake in Malang, the location of this study, is much higher than the national vaccination coverage with 2,534,372 (91.2%) having received a first dose and 2,416,046 (87.8%) a second dose (<xref ref-type="bibr" rid="ref24">24</xref>).</p>
<p>Accordingly, this study has four aims: (1) to investigate knowledge regarding COVID-19, willingness to receive a COVID-19 vaccine, vaccine uptake, and booster vaccine uptake among the general population in Malang, Indonesia; (2) to examine sociodemographic determinants of knowledge regarding COVID-19 among the general population in the district; (3) to examine the association of knowledge about COVID-19 on vaccine uptake and booster vaccine uptake among the general population in the district; and (4) to examine whether willingness to receive a vaccine mediates the linkage between knowledge regarding COVID-19 and vaccination uptake among the general population in the district.</p>
<p>Our main hypotheses are that individuals with more accurate knowledge regarding COVID-19 can better understand the disease and its risks, signs, and symptoms and are therefore more willing to receive a vaccine and more likely to do so. Likewise, individuals with less accurate knowledge regarding COVID-19 are more likely to misunderstand the disease or lack knowledge about it, rendering them less willing to accept a vaccine and less likely to receive one. Although this study focuses on Malang District, Indonesia, we hope that our findings will not only aid in designing and developing educational interventions specifically targeted to improve COVID-19 vaccine uptake in the district but also beyond the study location, especially in LMICs with similar health contexts.</p>
</sec>
<sec id="sec7" sec-type="methods">
<title>2. Methods</title>
<sec id="sec8">
<title>2.1. Study location</title>
<p>This study was conducted in the district of Malang, Jawa Timur, Indonesia, from November 01, 2022, to January 25, 2023, when the government of Indonesia declared COVID-19 an epidemic disease. The COVID-19 booster vaccination program had already been launched in the district. Malang is the second-largest district in East Java Province, with a 2022 population of 2,751,761 people distributed across 390 villages (273 or 70% of which are rural and 117 or 30% of which are urban). Malang has 39 primary healthcare centers (one for every 65,000 people) and 390 village health posts (one for every 7,000 people). Malang classifies 10.15% of its population as &#x201C;poor or near poor,&#x201D; compared to 11.46% in all of East Java province (<xref ref-type="bibr" rid="ref25">25</xref>). The Malang authority carried out its first COVID-19 vaccination program in January 2021 with 2 million doses of vaccine. It is reported that 2,589,407 people have been vaccinated (94.1%) (<xref ref-type="bibr" rid="ref24">24</xref>). The second and third phases of the vaccination campaign in Malang were carried out in May 2021 and January 2022, with 5.6 million doses of vaccines reaching 2,534,372 individuals (91.2%) and 2,416,046 individuals (87.8%), respectively (<xref ref-type="bibr" rid="ref18">18</xref>). The percentage of vaccination uptake for the first and second doses in Malang is higher than the national vaccination uptake, which is reported at 86% for the first dose and 57% for the second dose (<xref ref-type="bibr" rid="ref24">24</xref>).</p>
</sec>
<sec id="sec9">
<title>2.2. Study design and sampling method</title>
<p>This cross-sectional study was conducted among individuals aged 15&#x2013;99&#x2009;years. The sampling population was determined using a stratified sampling design, with the population stratified into urban and rural areas. Based on a confidence level of 99.0% and a margin of error of 2%, we found the minimum samples for rural and urban areas to be 4,151 and 4,139 respondents, respectively. Initially, 10,050 potential respondents (5,049 in rural areas and 5,001 in urban areas) provided written informed consent and agreed to participate in this study. To encourage participants to participate in the survey, we provided a door prize for 100 randomly selected participants at the end of the survey. Of 10,050 potential respondents, 10,007 were able to complete the survey.</p>
</sec>
<sec id="sec10">
<title>2.3. Data collection process</title>
<p>Before data collection, a pretest of the questionnaire was conducted in urban and rural villages at Mojokerto East Java from 12&#x2013;20 August 2022. The pretest focused on questionnaire content, field editing protocols, the use of data collection apps, and general field procedures. The results of the pilot survey indicated that all respondents could easily understand the questions. Overall, the survey took 30 to 40&#x2009;min to complete. We used KoboToolbox (a simple, robust, and powerful data collection app) to generate a questionnaire (<xref ref-type="bibr" rid="ref26">26</xref>). The survey apps were used by 160 trained field researchers in charge of data collection. All recruited field researchers underwent a thorough 2-day training to learn and practice using the survey app.</p>
<p><xref rid="fig1" ref-type="fig">Figure 1</xref> describes the data collection process in this study. The target population of this study was Malang district people age 15&#x2013;99&#x2009;years (<italic>N</italic>&#x2009;=&#x2009;2,201,408). The sampling frame of this study was a list of all registered Malang citizens aged 15&#x2013;99&#x2009;years who live in 390 villages retrieved from the district citizen registration official report 2021. We applied a stratified sampling design, with the population stratified into urban and rural areas (N target population for urban area&#x2009;=&#x2009;1,540,986 individuals, N target population for urban area&#x2009;=&#x2009;660,422 individuals). Based on a confidence level of 99.0% and a margin of error of 2%, we found the minimum samples for rural and urban areas to be 4,151 and 4,139 respondents, respectively.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Workflow of data collection in this study.</p>
</caption>
<graphic xlink:href="fpubh-11-1203550-g001.tif"/>
</fig>
<p>Trained field researchers in each village contacted potential participants to confirm their willingness to participate in the study. The field researchers were able to identify 10,050 potential respondents (5,049 in rural areas and 5,001 in urban areas) who agreed to participate in this study. Sixth, collecting data: trained field researchers collected data from all potential participants using the survey app. Written informed consent was obtained from all respondents before data collection. Prior to interviewing, respondents were informed about the importance of participating in the survey. Confidentiality and anonymity were also ensured during data collection. Due COVID-19 pandemic situation, the field researchers were equipped with several items of personal protective equipment for COVID-19 protection, including medical masks (N95 3&#x2009;M Type 9,010), face shields (headgear with clear visor), surgical gloves (Golden Glove latex), and hand sanitizer. Of 10,050 potential respondents, 10,007 were able to complete the survey.</p>
<p>Quality control was done in the field as well as in the University of Brawijaya office. In the field, it was the responsibility of the supervisor and data editor to listen to the recording interview for selected random interviews. In the first two enumeration areas, they had to listen to up to two interviews of each field researcher and thereafter randomly selected interviews. Supervisors also had the responsibility to do observation and verification of 10% of interviews. Verification was done by listening to parts of interview recordings. We also had a team of people in the University of Brawijaya office who listened to random parts of these recordings for random interviews and then compared answers to the electronic data. When discrepancies were found they got back to the teams, generally within the first week of the original interview for field researchers to re-check questionable answers.</p>
</sec>
<sec id="sec11">
<title>2.4. Measures</title>
<p>The dependent variables in this study were COVID-19 vaccine uptake and COVID-19 booster vaccine uptake. COVID-19 vaccine uptake was measured using the question: &#x201C;Have you received at least one dose of a COVID-19 vaccine as of today?.&#x201D; Likewise, COVID-19 booster vaccine uptake was measured using the question: &#x2018;Have you received at least three doses of a COVID-19 vaccine as of today?&#x201D; These questions were to be answered as either &#x201C;Yes&#x2014;have had at least one dose of vaccine/Yes&#x2014;have had at least three doses of vaccine&#x201D; or &#x201C;No&#x2014;have not had a first dose of vaccine/No&#x2014;have not had at least three doses of vaccine.&#x201D; These closed-ended questions indicated vaccine uptake and booster vaccine uptake (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
<p>The mediating variable was willingness to receive a COVID-19 vaccine. Respondents who responded &#x201C;No&#x2014;have not had a first dose of vaccine&#x201D; were asked the question: &#x201C;If a COVID-19 vaccine is available, are you willing to receive it?&#x201D; Respondents were to answer &#x201C;Willing to receive vaccine,&#x201D; &#x201C;Not willing to receive vaccine,&#x201D; or &#x201C;Undecided.&#x201D; Responses of &#x201C;Not willing to receive vaccine&#x201D; and &#x2018;Undecided&#x201D; were assigned as &#x201C;unwilling&#x201D; (<xref ref-type="bibr" rid="ref28">28</xref>, <xref ref-type="bibr" rid="ref29">29</xref>).</p>
<p>The main independent variable was knowledge about COVID-19; this was assessed using a six-item questionnaire developed by Zhong et al. (<xref ref-type="bibr" rid="ref30">30</xref>) and adopted in other similar studies (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). The questionnaire included three questions about the clinical characteristics of the disease (i.e., primary symptoms, availability and effectiveness of treatment, and severity). Two survey questions addressed transmission (i.e., infection through contact with animals and transmission through respiratory droplets), and one item covered prevention and control (i.e., wearing medical masks for prevention). The possible responses were: &#x201C;Yes,&#x201D; &#x201C;No,&#x201D; or &#x201C;Do not know.&#x201D; The knowledge scores were calculated by assigning one point to each correctly answered question and an aggregate score was calculated (range 0&#x2013;6), with higher scores indicating more knowledge about COVID-19 (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>We also included comorbidities and sociodemographic factors in the models. Comorbidities were measured through a respondent&#x2019;s history of hypertension, cardiovascular diseases, diabetes, stroke, autoimmune disease, kidney failure, cancer, gastritis, obesity, chronic obstructive pulmonary disease, and respiratory failure as diagnosed by a medical doctor (<xref ref-type="bibr" rid="ref33">33</xref>). Sociodemographic factors included gender, age, education, and monthly household income. Each respondent&#x2019;s educational level was classified based on the Indonesian education system: no schooling, elementary school, junior secondary school, high school, college, and university (<xref ref-type="bibr" rid="ref28">28</xref>). Household monthly income was classified into four categories based on standard monthly wages in Malang: &#x003C;1.8 million IDR, 1.8&#x2013;3 million IDR, 3&#x2013;4.8 million IDR, and&#x2009;&#x003E;&#x2009;4.8 million IDR (<xref ref-type="bibr" rid="ref34">34</xref>).</p>
</sec>
<sec id="sec12">
<title>2.5. Statistical analyses</title>
<p>To ensure that the sample was representative of people living in Malang at large, we generated descriptive statistics (percentages and 95% confidence intervals [CIs]) for the outcomes using cross-sectional weights. Linear regression was used to examine factors associated with knowledge about COVID-19. Logistic regression was performed to examine the association of knowledge about COVID-19 on vaccine uptake. Generalized structural equation modeling (GSEM) was used to examine whether willingness to receive vaccine mediates the association between knowledge about COVID-19 and vaccination uptake. The maximum likelihood (ML) estimator was used to estimate all models; for the probability model, we reported the odds ratio (OR), 95% confidence intervals (95% CIs), and a two-sided value of <italic>p</italic> of &#x003C;0.05 (<xref ref-type="bibr" rid="ref35">35</xref>). We used Delta, Sobel, and Monte Carlo tests to determine whether the reduction in the effect of the independent variable after including the mediator variable in the model was significant and, therefore, whether the mediation effect was statistically significant. STATA 17.1 was used to clean and analyze the data. Listwise deletion was used to remove missing data from the analyses, allowing each model to include a different number of participants.</p>
</sec>
<sec id="sec13">
<title>2.6. Ethics and consent</title>
<p>The survey was prefaced with a participant information statement and consent form in simple Bahasa (the local language). A trained interviewer read the statement and consent for every participant via the KoboToolbox survey app and confirmed that participants had understood the participant information statement to proceed to the survey; completion of the survey constituted consent. Ethics approval was granted by the Brawijaya University Ethical Board (Reference: 11/EC/KEPK/04/2021).</p>
</sec>
</sec>
<sec id="sec14" sec-type="results">
<title>3. Results</title>
<sec id="sec15">
<title>3.1. Respondent characteristics</title>
<p><xref rid="tab1" ref-type="table">Table 1</xref> describes the characteristics of the respondents. The percentage of respondents who reported having received at least one dose of a COVID-19 vaccine was 94.8%, while the percentage of those who reported having received at least three doses was 88.5%. These numbers were higher than the national average for COVID-19 vaccine and booster vaccine uptake. The average age of respondents was 43.6&#x2009;years old [standard deviation (SD)&#x2009;=&#x2009;15.0], which is slightly older than the average age of the same age range in the district in 2022. In 2022, the proportion of females in Malang&#x2019;s population was 49.6%, which is slightly higher than the proportion of female respondents in our study (47.9%). The educational status of respondents was similar to the educational status of Malang&#x2019;s population in 2022: the largest percentage of the population graduated from high school (35.5%). The greatest number of respondents reported a monthly household income of under 1.8 million rupiahs (49.9%). This percentage was also similar to the 49.6% found in the general population of the district in 2022. The proportion of respondents who reported being unemployed was 8.2%, while in 2022 the open unemployment rate in the district was 7.7% (<xref ref-type="bibr" rid="ref25">25</xref>). Most respondents reported having no comorbidities (91.8%). Among 10,007 respondents, 4.8% reported having hypertension, 0.9% reported having cardiovascular diseases, 1.1% reported having diabetes, 0.5% reported having chronic obstructive pulmonary disease and respiratory failure, and less than 0.5% reported having had a stroke or autoimmune disease, kidney failure, gastritis, and obesity.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Respondents&#x2019; characteristics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Variables</th>
<th align="center" valign="middle">% or mean</th>
<th align="center" valign="middle">SD</th>
<th align="center" valign="middle">Min</th>
<th align="center" valign="middle">Max</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Received a COVID-19 vaccine</td>
<td align="char" valign="bottom" char=".">94.8%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Received a COVID-19 booster vaccine</td>
<td align="char" valign="bottom" char=".">88.5%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Willing to receive a COVID-19 vaccine</td>
<td align="char" valign="bottom" char=".">83.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">COVID-19 knowledge score</td>
<td align="char" valign="bottom" char=".">4.6</td>
<td align="center" valign="bottom">1.1</td>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">6</td>
</tr>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="char" valign="bottom" char=".">43.6</td>
<td align="center" valign="bottom">15.0</td>
<td align="center" valign="bottom">15</td>
<td align="center" valign="bottom">99</td>
</tr>
<tr>
<td align="left" valign="bottom">Sex</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Male</td>
<td align="char" valign="bottom" char=".">52.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Female</td>
<td align="char" valign="bottom" char=".">47.9%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Educational level</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No schooling</td>
<td align="char" valign="bottom" char=".">1.6%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Elementary school</td>
<td align="char" valign="bottom" char=".">31.9%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Junior secondary school</td>
<td align="char" valign="bottom" char=".">24.3%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">High school</td>
<td align="char" valign="bottom" char=".">34.6%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">College</td>
<td align="char" valign="bottom" char=".">3.3%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">University</td>
<td align="char" valign="bottom" char=".">4.2%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Household monthly income (IDR)</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">&#x003C;1.8 million</td>
<td align="char" valign="bottom" char=".">49.9%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">1.8&#x2013;3 million</td>
<td align="char" valign="bottom" char=".">36.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">3&#x2013;4.8 million</td>
<td align="char" valign="bottom" char=".">11.0%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">&#x003E;4.8 million</td>
<td align="char" valign="bottom" char=".">3.0%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Employment status</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Employed</td>
<td align="char" valign="bottom" char=".">91.8%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Unemployed</td>
<td align="char" valign="bottom" char=".">8.2%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Comorbidity status</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">No comorbidities</td>
<td align="char" valign="bottom" char=".">91.2%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Hypertension</td>
<td align="char" valign="bottom" char=".">4.8%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Cardiovascular diseases</td>
<td align="char" valign="bottom" char=".">0.9%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Diabetes</td>
<td align="char" valign="bottom" char=".">1.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke</td>
<td align="char" valign="bottom" char=".">0.4%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Autoimmune disease</td>
<td align="char" valign="bottom" char=".">0.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Kidney failure</td>
<td align="char" valign="bottom" char=".">0.1%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Chronic obstructive pulmonary disease and respiratory failure</td>
<td align="char" valign="bottom" char=".">0.5%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Obesity</td>
<td align="char" valign="bottom" char=".">0.2%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Cancer</td>
<td align="char" valign="bottom" char=".">0.2%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">Gastritis</td>
<td align="char" valign="bottom" char=".">0.4%</td>
<td/>
<td align="center" valign="bottom">0</td>
<td align="center" valign="bottom">1</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec16">
<title>3.2. Respondents&#x2019; knowledge regarding COVID-19</title>
<p>Most respondents answered about four of six knowledge items correctly (<italic>M</italic>&#x2009;=&#x2009;4.60, SD&#x2009;=&#x2009;1.1). Respondents appeared to be knowledgeable about transmission through respiratory droplets from infected people (92.9% answered correctly, 1.3% incorrectly, and 5.8% reported that they did not know). The highest prevalence of misunderstanding was discovered in the knowledge item regarding infection through eating or having contact with wild animals (<xref rid="tab2" ref-type="table">Table 2</xref>). Only 24.5% correctly answered that transmission does not occur in this way and that the statement was therefore false, while 59.0% believed that it was true and 16.4% responded that they did not know. Most of the respondents (98.2%) correctly replied that wearing a general medical mask aids in prevention, 0.8% answered incorrectly, and 1.0% did not know.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Respondents&#x2019; knowledge about COVID-19.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">#</th>
<th align="left" valign="middle" rowspan="2">COVID-19 knowledge items</th>
<th align="center" valign="middle" colspan="2">Yes</th>
<th align="center" valign="middle" colspan="2">No</th>
<th align="center" valign="middle" colspan="2">Do not know</th>
</tr>
<tr>
<th align="center" valign="middle"><italic>N</italic>
</th>
<th align="center" valign="middle">%</th>
<th align="center" valign="middle"><italic>N</italic>
</th>
<th align="center" valign="middle">%</th>
<th align="center" valign="middle"><italic>N</italic>
</th>
<th align="center" valign="middle">%</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">1</td>
<td align="left" valign="bottom">The main clinical symptoms of COVID-19 are fever, fatigue, dry cough, and myalgia.</td>
<td align="center" valign="top">9,292</td>
<td align="char" valign="top" char=".">92.9%</td>
<td align="center" valign="top">134</td>
<td align="char" valign="top" char=".">1.3%</td>
<td align="center" valign="top">581</td>
<td align="char" valign="top" char=".">5.8%</td>
</tr>
<tr>
<td align="left" valign="top">2</td>
<td align="left" valign="bottom">There currently is no effective cure for COVID-19, but early symptomatic and supportive treatment can help most patients recover from infection.</td>
<td align="center" valign="top">8,319</td>
<td align="char" valign="top" char=".">83.1%</td>
<td align="center" valign="top">278</td>
<td align="char" valign="top" char=".">2.8%</td>
<td align="center" valign="top">1,410</td>
<td align="char" valign="top" char=".">14.1%</td>
</tr>
<tr>
<td align="left" valign="top">3</td>
<td align="left" valign="bottom">Not all persons with COVID-2019 will develop severe cases. Only those who are older adult and have chronic illnesses are more likely to develop severe cases.</td>
<td align="center" valign="top">7,640</td>
<td align="char" valign="top" char=".">76.3%</td>
<td align="center" valign="top">1,275</td>
<td align="char" valign="top" char=".">12.7%</td>
<td align="center" valign="top">1,092</td>
<td align="char" valign="top" char=".">10.9%</td>
</tr>
<tr>
<td align="left" valign="top">4</td>
<td align="left" valign="bottom">Eating or having contact with wild animals could result in infection with the COVID-19 virus.</td>
<td align="center" valign="top">5,908</td>
<td align="char" valign="top" char=".">59.0%</td>
<td align="center" valign="top">2,455</td>
<td align="char" valign="top" char=".">24.5%</td>
<td align="center" valign="top">1,644</td>
<td align="char" valign="top" char=".">16.4%</td>
</tr>
<tr>
<td align="left" valign="top">5</td>
<td align="left" valign="bottom">The COVID-19 virus spreads via respiratory droplets from infected individuals.</td>
<td align="center" valign="top">8,433</td>
<td align="char" valign="top" char=".">84.3%</td>
<td align="center" valign="top">1,146</td>
<td align="char" valign="top" char=".">11.5%</td>
<td align="center" valign="top">428</td>
<td align="char" valign="top" char=".">4.3%</td>
</tr>
<tr>
<td align="left" valign="top">6</td>
<td align="left" valign="bottom">Ordinary citizens can wear general medical masks to prevent infection by the COVID-19 virus.</td>
<td align="center" valign="top">9,826</td>
<td align="char" valign="top" char=".">98.2%</td>
<td align="center" valign="top">83</td>
<td align="char" valign="top" char=".">0.8%</td>
<td align="center" valign="top">98</td>
<td align="char" valign="top" char=".">1.0%</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec17">
<title>3.3. Sociodemographic determinants of COVID-19 knowledge</title>
<p>Knowledge scores varied according to age, educational level, income, and employment status (<xref rid="tab3" ref-type="table">Table 3</xref>). Older respondents were less likely to have accurate information about COVID-19 [<italic>&#x03B2;</italic>&#x2009;=&#x2009;&#x2212;0.003, 95% CI&#x2009;=&#x2009;&#x2212;0.005&#x2013;(&#x2212;0.002)]. Respondents who were educated at the elementary, junior secondary, high school, college, and university levels were more likely to have accurate information about COVID-19. Respondents with higher economic status were more likely to have accurate information about COVID-19. Unemployed respondents were less likely to have accurate information about COVID-19 [<italic>&#x03B2;</italic>&#x2009;=&#x2009;&#x2212;0.236, 95% CI&#x2009;=&#x2009;&#x2212;0.313&#x2013;(&#x2212;0.160)]. Gender was not related to knowledge about COVID-19.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Sociodemographic determinants of COVID-19 knowledge.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Variables</th>
<th align="center" valign="middle" rowspan="2">Coef.</th>
<th align="center" valign="middle" rowspan="2">SE</th>
<th align="center" valign="middle" rowspan="2">Value of <italic>p</italic></th>
<th align="center" valign="middle" colspan="2">95% CI</th>
</tr>
<tr>
<th align="center" valign="middle">Lower</th>
<th align="center" valign="middle">Upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="char" valign="bottom" char=".">&#x2212;0.003</td>
<td align="char" valign="bottom" char=".">0.001</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">&#x2212;0.005</td>
<td align="char" valign="bottom" char=".">&#x2212;0.002</td>
</tr>
<tr>
<td align="left" valign="bottom">Female</td>
<td align="char" valign="bottom" char=".">&#x2212;0.004</td>
<td align="char" valign="bottom" char=".">0.021</td>
<td align="char" valign="bottom" char=".">0.833</td>
<td align="char" valign="bottom" char=".">&#x2212;0.046</td>
<td align="char" valign="bottom" char=".">0.037</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Educational status (reference&#x2009;=&#x2009;no schooling)</td>
</tr>
<tr>
<td align="left" valign="bottom">Elementary school</td>
<td align="char" valign="top" char=".">0.332</td>
<td align="char" valign="top" char=".">0.086</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.163</td>
<td align="char" valign="top" char=".">0.501</td>
</tr>
<tr>
<td align="left" valign="bottom">Junior secondary school</td>
<td align="char" valign="top" char=".">0.361</td>
<td align="char" valign="top" char=".">0.089</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.187</td>
<td align="char" valign="top" char=".">0.535</td>
</tr>
<tr>
<td align="left" valign="bottom">High school</td>
<td align="char" valign="bottom" char=".">0.428</td>
<td align="char" valign="bottom" char=".">0.089</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">0.253</td>
<td align="char" valign="bottom" char=".">0.602</td>
</tr>
<tr>
<td align="left" valign="bottom">College</td>
<td align="char" valign="bottom" char=".">0.633</td>
<td align="char" valign="bottom" char=".">0.105</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">0.427</td>
<td align="char" valign="bottom" char=".">0.839</td>
</tr>
<tr>
<td align="left" valign="bottom">University</td>
<td align="char" valign="bottom" char=".">0.515</td>
<td align="char" valign="bottom" char=".">0.101</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">0.316</td>
<td align="char" valign="bottom" char=".">0.714</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Household monthly income (IDR) (reference&#x2009;=&#x2009;&#x003C;1.8 million)</td>
</tr>
<tr>
<td align="left" valign="bottom">1.8&#x2013;3 million</td>
<td align="char" valign="bottom" char=".">0.172</td>
<td align="char" valign="bottom" char=".">0.024</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">0.125</td>
<td align="char" valign="bottom" char=".">0.218</td>
</tr>
<tr>
<td align="left" valign="bottom">3&#x2013;4.8 million</td>
<td align="char" valign="bottom" char=".">0.112</td>
<td align="char" valign="bottom" char=".">0.036</td>
<td align="char" valign="bottom" char=".">0.002</td>
<td align="char" valign="bottom" char=".">0.041</td>
<td align="char" valign="bottom" char=".">0.183</td>
</tr>
<tr>
<td align="left" valign="bottom">&#x003E;4.8 million</td>
<td align="char" valign="bottom" char=".">0.183</td>
<td align="char" valign="bottom" char=".">0.064</td>
<td align="char" valign="bottom" char=".">0.004</td>
<td align="char" valign="bottom" char=".">0.058</td>
<td align="char" valign="bottom" char=".">0.308</td>
</tr>
<tr>
<td align="left" valign="bottom">Unemployed</td>
<td align="char" valign="bottom" char=".">&#x2212;0.236</td>
<td align="char" valign="bottom" char=".">0.039</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">&#x2212;0.313</td>
<td align="char" valign="bottom" char=".">&#x2212;0.160</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="bottom" char=".">4.298</td>
<td align="char" valign="bottom" char=".">0.100</td>
<td align="char" valign="bottom" char=".">0.000</td>
<td align="char" valign="bottom" char=".">4.102</td>
<td align="char" valign="bottom" char=".">4.494</td>
</tr>
<tr>
<td align="left" valign="bottom">Adjusted R<sup>2</sup></td>
<td align="char" valign="bottom" char=".">0.025</td>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec18">
<title>3.4. Determinants of COVID-19 vaccine uptake and booster vaccine uptake</title>
<p><xref rid="tab4" ref-type="table">Table 4</xref> describes the determinants of COVID-19 vaccine uptake. Respondents who had more accurate knowledge about COVID-19 were more likely to be vaccinated (OR&#x2009;=&#x2009;1.528, 95% CI&#x2009;=&#x2009;1.428&#x2013;1.634). Being older (OR&#x2009;=&#x2009;0.984, 95% CI&#x2009;=&#x2009;0.977&#x2013;0.991) and being female (OR&#x2009;=&#x2009;0.819, 95% CI&#x2009;=&#x2009;0.676&#x2013;0.994) were associated with lower COVID-19 vaccination uptake. Respondents with a university education were more likely to be vaccinated than those with no schooling (OR&#x2009;=&#x2009;2.408, 95% CI&#x2009;=&#x2009;0.877&#x2013;6.609). Null associations were found for respondents with elementary school, junior secondary, high school, and college education. Respondents with a monthly household income of more than 4.8 million rupiahs, 3&#x2013;4.8 million rupiahs, and 1.8&#x2013;3 million rupiahs were more likely to be vaccinated than respondents with incomes of less than 1.8 million rupiahs. The null association was found for respondents with a monthly household income of 3&#x2013;4.8 million rupiah. Unemployed respondents were less likely to be vaccinated than employed respondents (OR&#x2009;=&#x2009;0.348, 95% CI&#x2009;=&#x2009;0.270&#x2013;0.448). As expected, most respondents who have comorbidities were less likely to get vaccinated compared to those who did not have comorbidities.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Logistic regression results of COVID-19 vaccine uptake.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Variables</th>
<th align="center" valign="middle" rowspan="2">OR</th>
<th align="center" valign="middle" rowspan="2">SE</th>
<th align="center" valign="middle" rowspan="2">Value of <italic>p</italic></th>
<th align="center" valign="middle" colspan="2">95% CI</th>
</tr>
<tr>
<th align="center" valign="middle">Lower</th>
<th align="center" valign="middle">UPPER</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">COVID-19 knowledge score</td>
<td align="char" valign="top" char=".">1.528</td>
<td align="char" valign="top" char=".">0.052</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">1.428</td>
<td align="char" valign="top" char=".">1.634</td>
</tr>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="char" valign="top" char=".">0.984</td>
<td align="char" valign="top" char=".">0.004</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.977</td>
<td align="char" valign="top" char=".">0.991</td>
</tr>
<tr>
<td align="left" valign="bottom">Female (reference&#x2009;=&#x2009;male)</td>
<td align="char" valign="top" char=".">0.819</td>
<td align="char" valign="top" char=".">0.081</td>
<td align="char" valign="top" char=".">0.043</td>
<td align="char" valign="top" char=".">0.676</td>
<td align="char" valign="top" char=".">0.994</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Education status (reference&#x2009;=&#x2009;no schooling)</td>
</tr>
<tr>
<td align="left" valign="bottom">Elementary school</td>
<td align="char" valign="top" char=".">0.768</td>
<td align="char" valign="top" char=".">0.201</td>
<td align="char" valign="top" char=".">0.313</td>
<td align="char" valign="top" char=".">0.460</td>
<td align="char" valign="top" char=".">1.283</td>
</tr>
<tr>
<td align="left" valign="bottom">Junior secondary school</td>
<td align="char" valign="top" char=".">0.985</td>
<td align="char" valign="top" char=".">0.281</td>
<td align="char" valign="top" char=".">0.959</td>
<td align="char" valign="top" char=".">0.564</td>
<td align="char" valign="top" char=".">1.722</td>
</tr>
<tr>
<td align="left" valign="bottom">High school</td>
<td align="char" valign="top" char=".">1.697</td>
<td align="char" valign="top" char=".">0.499</td>
<td align="char" valign="top" char=".">0.072</td>
<td align="char" valign="top" char=".">0.954</td>
<td align="char" valign="top" char=".">3.021</td>
</tr>
<tr>
<td align="left" valign="bottom">College</td>
<td align="char" valign="top" char=".">1.520</td>
<td align="char" valign="top" char=".">0.743</td>
<td align="char" valign="top" char=".">0.391</td>
<td align="char" valign="top" char=".">0.583</td>
<td align="char" valign="top" char=".">3.961</td>
</tr>
<tr>
<td align="left" valign="bottom">University</td>
<td align="char" valign="top" char=".">2.408</td>
<td align="char" valign="top" char=".">1.240</td>
<td align="char" valign="top" char=".">0.088</td>
<td align="char" valign="top" char=".">0.877</td>
<td align="char" valign="top" char=".">6.609</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Household monthly income (IDR) (reference&#x2009;=&#x2009;&#x003C;1.8 million)</td>
</tr>
<tr>
<td align="left" valign="bottom">1.8&#x2013;3 million</td>
<td align="char" valign="top" char=".">1.490</td>
<td align="char" valign="top" char=".">0.175</td>
<td align="char" valign="top" char=".">0.001</td>
<td align="char" valign="top" char=".">1.184</td>
<td align="char" valign="top" char=".">1.876</td>
</tr>
<tr>
<td align="left" valign="bottom">3&#x2013;4.8 million</td>
<td align="char" valign="top" char=".">1.331</td>
<td align="char" valign="top" char=".">0.257</td>
<td align="char" valign="top" char=".">0.138</td>
<td align="char" valign="top" char=".">0.912</td>
<td align="char" valign="top" char=".">1.942</td>
</tr>
<tr>
<td align="left" valign="bottom">&#x003E;4.8 million</td>
<td align="char" valign="top" char=".">5.296</td>
<td align="char" valign="top" char=".">3.444</td>
<td align="char" valign="top" char=".">0.010</td>
<td align="char" valign="top" char=".">1.480</td>
<td align="char" valign="top" char=".">18.948</td>
</tr>
<tr>
<td align="left" valign="bottom">Unemployed</td>
<td align="char" valign="top" char=".">0.348</td>
<td align="char" valign="top" char=".">0.045</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.270</td>
<td align="char" valign="top" char=".">0.448</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Comorbidity status (reference&#x2009;=&#x2009;no comorbidities)</td>
</tr>
<tr>
<td align="left" valign="bottom">Hypertension</td>
<td align="char" valign="top" char=".">0.498</td>
<td align="char" valign="top" char=".">0.082</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.360</td>
<td align="char" valign="top" char=".">0.688</td>
</tr>
<tr>
<td align="left" valign="bottom">Cardiovascular diseases</td>
<td align="char" valign="top" char=".">0.177</td>
<td align="char" valign="top" char=".">0.049</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.103</td>
<td align="char" valign="top" char=".">0.304</td>
</tr>
<tr>
<td align="left" valign="bottom">Diabetes</td>
<td align="char" valign="top" char=".">0.140</td>
<td align="char" valign="top" char=".">0.034</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.087</td>
<td align="char" valign="top" char=".">0.225</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke</td>
<td align="char" valign="top" char=".">0.075</td>
<td align="char" valign="top" char=".">0.027</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.037</td>
<td align="char" valign="top" char=".">0.150</td>
</tr>
<tr>
<td align="left" valign="bottom">Autoimmune</td>
<td align="char" valign="top" char=".">0.240</td>
<td align="char" valign="top" char=".">0.213</td>
<td align="char" valign="top" char=".">0.108</td>
<td align="char" valign="top" char=".">0.042</td>
<td align="char" valign="top" char=".">1.367</td>
</tr>
<tr>
<td align="left" valign="bottom">Kidney failure</td>
<td align="char" valign="top" char=".">0.058</td>
<td align="char" valign="top" char=".">0.040</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.015</td>
<td align="char" valign="top" char=".">0.226</td>
</tr>
<tr>
<td align="left" valign="bottom">Chronic obstructive pulmonary disease</td>
<td align="char" valign="top" char=".">0.169</td>
<td align="char" valign="top" char=".">0.061</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.083</td>
<td align="char" valign="top" char=".">0.341</td>
</tr>
<tr>
<td align="left" valign="bottom">Obesity</td>
<td align="char" valign="top" char=".">1.457</td>
<td align="char" valign="top" char=".">2.097</td>
<td align="char" valign="top" char=".">0.794</td>
<td align="char" valign="top" char=".">0.087</td>
<td align="char" valign="top" char=".">24.486</td>
</tr>
<tr>
<td align="left" valign="bottom">Cancer</td>
<td align="char" valign="top" char=".">0.111</td>
<td align="char" valign="top" char=".">0.055</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.042</td>
<td align="char" valign="top" char=".">0.294</td>
</tr>
<tr>
<td align="left" valign="bottom">Gastritis</td>
<td align="char" valign="top" char=".">0.168</td>
<td align="char" valign="top" char=".">0.076</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.069</td>
<td align="char" valign="top" char=".">0.407</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="top" char=".">8.118</td>
<td align="char" valign="top" char=".">2.978</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">3.955</td>
<td align="char" valign="top" char=".">16.661</td>
</tr>
</tbody>
</table>
</table-wrap>
<p><xref rid="tab5" ref-type="table">Table 5</xref> shows the determinants of COVID-19 booster vaccine uptake. Respondents who had more accurate knowledge about COVID-19 were more likely to have received booster vaccination (OR&#x2009;=&#x2009;1.260, 95% CI&#x2009;=&#x2009;1.196&#x2013;1.328). Being older (OR&#x2009;=&#x2009;0.987, 95% CI&#x2009;=&#x2009;0.982&#x2013;0.992) and being female (OR&#x2009;=&#x2009;0.814, 95% CI&#x2009;=&#x2009;0.715&#x2013;0.928) were associated with lower COVID-19 booster vaccination uptake. Respondents with high school and university education were more likely to have received booster vaccination than those with no schooling (OR&#x2009;=&#x2009;1.535, 95% CI&#x2009;=&#x2009;0.984&#x2013;2.397; OR&#x2009;=&#x2009;2.408, 95% CI&#x2009;=&#x2009;0.877&#x2013;6.609, respectively). Null associations were found for respondents with elementary school, junior secondary school, and college education. Respondents with a monthly household income of 3&#x2013;4.8 million rupiahs and 1.8&#x2013;3 million rupiahs were more likely to have received booster vaccination than respondents with an income of less than 1.8 million rupiahs. The null association was found for respondents with a monthly household income of more than 4.8 million rupiahs. Unemployed respondents were less likely to have received booster vaccination than employed respondents (OR&#x2009;=&#x2009;0.522, 95% CI&#x2009;=&#x2009;0.427&#x2013;0.638). As expected, respondents who had comorbidities were less likely to have received booster vaccination than those who had no comorbidities.</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Logistic regression results of COVID-19 booster vaccination uptake.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Variables</th>
<th align="center" valign="middle" rowspan="2">OR</th>
<th align="center" valign="middle" rowspan="2">SE</th>
<th align="center" valign="middle" rowspan="2">Value of <italic>p</italic></th>
<th align="center" valign="middle" colspan="2">95% CI</th>
</tr>
<tr>
<th align="center" valign="middle">Lower</th>
<th align="center" valign="middle">Upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">COVID-19 knowledge score</td>
<td align="char" valign="top" char=".">1.260</td>
<td align="char" valign="top" char=".">0.034</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">1.196</td>
<td align="char" valign="top" char=".">1.328</td>
</tr>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="char" valign="top" char=".">0.987</td>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.982</td>
<td align="char" valign="top" char=".">0.992</td>
</tr>
<tr>
<td align="left" valign="bottom">Female</td>
<td align="char" valign="top" char=".">0.814</td>
<td align="char" valign="top" char=".">0.054</td>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.715</td>
<td align="char" valign="top" char=".">0.928</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Education status (reference&#x2009;=&#x2009;no schooling)</td>
</tr>
<tr>
<td align="left" valign="bottom">Elementary school</td>
<td align="char" valign="top" char=".">0.715</td>
<td align="char" valign="top" char=".">0.151</td>
<td align="char" valign="top" char=".">0.111</td>
<td align="char" valign="top" char=".">0.473</td>
<td align="char" valign="top" char=".">1.081</td>
</tr>
<tr>
<td align="left" valign="bottom">Junior secondary school</td>
<td align="char" valign="top" char=".">1.028</td>
<td align="char" valign="top" char=".">0.230</td>
<td align="char" valign="top" char=".">0.902</td>
<td align="char" valign="top" char=".">0.663</td>
<td align="char" valign="top" char=".">1.593</td>
</tr>
<tr>
<td align="left" valign="bottom">High school</td>
<td align="char" valign="top" char=".">1.535</td>
<td align="char" valign="top" char=".">0.349</td>
<td align="char" valign="top" char=".">0.059</td>
<td align="char" valign="top" char=".">0.984</td>
<td align="char" valign="top" char=".">2.397</td>
</tr>
<tr>
<td align="left" valign="bottom">College</td>
<td align="char" valign="top" char=".">1.569</td>
<td align="char" valign="top" char=".">0.513</td>
<td align="char" valign="top" char=".">0.168</td>
<td align="char" valign="top" char=".">0.827</td>
<td align="char" valign="top" char=".">2.978</td>
</tr>
<tr>
<td align="left" valign="bottom">University</td>
<td align="char" valign="top" char=".">1.764</td>
<td align="char" valign="top" char=".">0.548</td>
<td align="char" valign="top" char=".">0.068</td>
<td align="char" valign="top" char=".">0.960</td>
<td align="char" valign="top" char=".">3.244</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Household monthly income (IDR) (reference&#x2009;=&#x2009;&#x003C;1.8 million)</td>
</tr>
<tr>
<td align="left" valign="bottom">1.8&#x2013;3 million</td>
<td align="char" valign="top" char=".">1.574</td>
<td align="char" valign="top" char=".">0.122</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">1.352</td>
<td align="char" valign="top" char=".">1.832</td>
</tr>
<tr>
<td align="left" valign="bottom">3&#x2013;4.8 million</td>
<td align="char" valign="top" char=".">1.511</td>
<td align="char" valign="top" char=".">0.195</td>
<td align="char" valign="top" char=".">0.001</td>
<td align="char" valign="top" char=".">1.173</td>
<td align="char" valign="top" char=".">1.947</td>
</tr>
<tr>
<td align="left" valign="bottom">&#x003E;4.8 million</td>
<td align="char" valign="top" char=".">1.202</td>
<td align="char" valign="top" char=".">0.262</td>
<td align="char" valign="top" char=".">0.399</td>
<td align="char" valign="top" char=".">0.784</td>
<td align="char" valign="top" char=".">1.842</td>
</tr>
<tr>
<td align="left" valign="bottom">Unemployed</td>
<td align="char" valign="top" char=".">0.522</td>
<td align="char" valign="top" char=".">0.053</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.427</td>
<td align="char" valign="top" char=".">0.638</td>
</tr>
<tr>
<td align="left" valign="bottom" colspan="6">Comorbidity status (reference&#x2009;=&#x2009;no comorbidities)</td>
</tr>
<tr>
<td align="left" valign="bottom">Hypertension</td>
<td align="char" valign="top" char=".">0.675</td>
<td align="char" valign="top" char=".">0.086</td>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.526</td>
<td align="char" valign="top" char=".">0.868</td>
</tr>
<tr>
<td align="left" valign="bottom">Cardiovascular diseases</td>
<td align="char" valign="top" char=".">0.437</td>
<td align="char" valign="top" char=".">0.111</td>
<td align="char" valign="top" char=".">0.001</td>
<td align="char" valign="top" char=".">0.266</td>
<td align="char" valign="top" char=".">0.718</td>
</tr>
<tr>
<td align="left" valign="bottom">Diabetes</td>
<td align="char" valign="top" char=".">0.233</td>
<td align="char" valign="top" char=".">0.050</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.154</td>
<td align="char" valign="top" char=".">0.354</td>
</tr>
<tr>
<td align="left" valign="bottom">Stroke</td>
<td align="char" valign="top" char=".">0.165</td>
<td align="char" valign="top" char=".">0.055</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.087</td>
<td align="char" valign="top" char=".">0.316</td>
</tr>
<tr>
<td align="left" valign="bottom">Autoimmune</td>
<td align="char" valign="top" char=".">0.710</td>
<td align="char" valign="top" char=".">0.625</td>
<td align="char" valign="top" char=".">0.697</td>
<td align="char" valign="top" char=".">0.127</td>
<td align="char" valign="top" char=".">3.987</td>
</tr>
<tr>
<td align="left" valign="bottom">Kidney failure</td>
<td align="char" valign="top" char=".">0.194</td>
<td align="char" valign="top" char=".">0.135</td>
<td align="char" valign="top" char=".">0.019</td>
<td align="char" valign="top" char=".">0.049</td>
<td align="char" valign="top" char=".">0.760</td>
</tr>
<tr>
<td align="left" valign="bottom">Chronic obstructive pulmonary disease</td>
<td align="char" valign="top" char=".">0.347</td>
<td align="char" valign="top" char=".">0.110</td>
<td align="char" valign="top" char=".">0.001</td>
<td align="char" valign="top" char=".">0.187</td>
<td align="char" valign="top" char=".">0.645</td>
</tr>
<tr>
<td align="left" valign="bottom">Obesity</td>
<td align="char" valign="top" char=".">0.380</td>
<td align="char" valign="top" char=".">0.208</td>
<td align="char" valign="top" char=".">0.077</td>
<td align="char" valign="top" char=".">0.130</td>
<td align="char" valign="top" char=".">1.111</td>
</tr>
<tr>
<td align="left" valign="bottom">Cancer</td>
<td align="char" valign="top" char=".">0.354</td>
<td align="char" valign="top" char=".">0.168</td>
<td align="char" valign="top" char=".">0.029</td>
<td align="char" valign="top" char=".">0.139</td>
<td align="char" valign="top" char=".">0.899</td>
</tr>
<tr>
<td align="left" valign="bottom">Gastritis</td>
<td align="char" valign="top" char=".">0.180</td>
<td align="char" valign="top" char=".">0.063</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.091</td>
<td align="char" valign="top" char=".">0.359</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="top" char=".">5.388</td>
<td align="char" valign="top" char=".">1.532</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">3.086</td>
<td align="char" valign="top" char=".">9.407</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec19">
<title>3.5. Mediation analyses</title>
<p>The indirect effects of knowledge (<italic>scorekn</italic>) on vaccine uptake (<italic>vaccineupatke</italic>) mediated by willingness to receive vaccination (<italic>willvaccine</italic>) were significant (<xref rid="fig2" ref-type="fig">Figure 2</xref>; <xref rid="tab6" ref-type="table">Table 6</xref>). The Sobel, Delta, and Monte Carlo tests measuring the statistical significance of indirect effects also showed significance (indirect effect&#x2009;=&#x2009;0.018, SE&#x2009;=&#x2009;0.002, <italic>value of p</italic>&#x2009;=&#x2009;0.000, z-value&#x2009;=&#x2009;7.123, 95% CI&#x2009;=&#x2009;0.013&#x2013;0.023).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Results of GSEM of the association between COVID-19 knowledge and vaccine uptake with willingness to receive vaccine as the mediation variable.</p>
</caption>
<graphic xlink:href="fpubh-11-1203550-g002.tif"/>
</fig>
<table-wrap position="float" id="tab6">
<label>Table 6</label>
<caption>
<p>Results of GSEM of the association between COVID-19 knowledge and vaccine uptake with willingness to receive vaccine as the mediation variable.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Variables</th>
<th align="center" valign="middle" rowspan="2">Coef.</th>
<th align="center" valign="middle" rowspan="2">SE</th>
<th align="center" valign="middle" rowspan="2">Value of <italic>p</italic></th>
<th align="center" valign="middle" colspan="2">95% CI</th>
</tr>
<tr>
<th align="center" valign="middle">Lower</th>
<th align="center" valign="middle">Upper</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom" colspan="6">COVID-19 knowledge score</td>
</tr>
<tr>
<td align="left" valign="bottom">Unemployed</td>
<td align="char" valign="top" char=".">&#x2212;0.269</td>
<td align="char" valign="top" char=".">0.039</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">&#x2212;0.344</td>
<td align="char" valign="top" char=".">&#x2212;0.193</td>
</tr>
<tr>
<td align="left" valign="bottom">Monthly household income</td>
<td align="char" valign="top" char=".">0.082</td>
<td align="char" valign="top" char=".">0.014</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.054</td>
<td align="char" valign="top" char=".">0.110</td>
</tr>
<tr>
<td align="left" valign="bottom">Educational level</td>
<td align="char" valign="top" char=".">0.061</td>
<td align="char" valign="top" char=".">0.011</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.039</td>
<td align="char" valign="top" char=".">0.083</td>
</tr>
<tr>
<td align="left" valign="bottom">Female</td>
<td align="char" valign="top" char=".">0.004</td>
<td align="char" valign="top" char=".">0.021</td>
<td align="char" valign="top" char=".">0.856</td>
<td align="char" valign="top" char=".">&#x2212;0.037</td>
<td align="char" valign="top" char=".">0.045</td>
</tr>
<tr>
<td align="left" valign="bottom">Age</td>
<td align="char" valign="top" char=".">&#x2212;0.004</td>
<td align="char" valign="top" char=".">0.001</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">&#x2212;0.005</td>
<td align="char" valign="top" char=".">&#x2212;0.002</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="top" char=".">4.441</td>
<td align="char" valign="top" char=".">0.060</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">4.323</td>
<td align="char" valign="top" char=".">4.558</td>
</tr>
<tr>
<td align="left" valign="bottom" char="." colspan="6">Willingness to receive vaccine</td>
</tr>
<tr>
<td align="left" valign="bottom">COVID-19 knowledge score</td>
<td align="char" valign="top" char=".">0.042</td>
<td align="char" valign="top" char=".">0.006</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.030</td>
<td align="char" valign="top" char=".">0.053</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="top" char=".">0.646</td>
<td align="char" valign="top" char=".">0.026</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.594</td>
<td align="char" valign="top" char=".">0.697</td>
</tr>
<tr>
<td align="left" valign="bottom" char="." colspan="6">Vaccine uptake</td>
</tr>
<tr>
<td align="left" valign="bottom">Willingness to receive vaccine</td>
<td align="char" valign="top" char=".">0.426</td>
<td align="char" valign="top" char=".">0.014</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.399</td>
<td align="char" valign="top" char=".">0.454</td>
</tr>
<tr>
<td align="left" valign="bottom">Constant</td>
<td align="char" valign="top" char=".">0.523</td>
<td align="char" valign="top" char=".">0.013</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.499</td>
<td align="char" valign="top" char=".">0.548</td>
</tr>
<tr>
<td align="left" valign="bottom">Var (e.COVID-19 knowledge score)</td>
<td align="char" valign="top" char=".">1.090</td>
<td align="char" valign="top" char=".">0.015</td>
<td/>
<td align="char" valign="top" char=".">1.060</td>
<td align="char" valign="top" char=".">1.121</td>
</tr>
<tr>
<td align="left" valign="bottom">Var (e.Willingness to receive vaccine)</td>
<td align="char" valign="top" char=".">0.138</td>
<td align="char" valign="top" char=".">0.003</td>
<td/>
<td align="char" valign="top" char=".">0.131</td>
<td align="char" valign="top" char=".">0.145</td>
</tr>
<tr>
<td align="left" valign="bottom">Var (e.Vaccine uptake)</td>
<td align="char" valign="top" char=".">0.082</td>
<td align="char" valign="top" char=".">0.002</td>
<td/>
<td align="char" valign="top" char=".">0.078</td>
<td align="char" valign="top" char=".">0.086</td>
</tr>
<tr>
<td align="left" valign="bottom">Indirect effect</td>
<td align="char" valign="top" char=".">0.018</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="bottom">Delta test</td>
<td/>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.013</td>
<td align="char" valign="top" char=".">0.023</td>
</tr>
<tr>
<td align="left" valign="bottom">Sobel test</td>
<td/>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.013</td>
<td align="char" valign="top" char=".">0.023</td>
</tr>
<tr>
<td align="left" valign="bottom">Monte Carlo test</td>
<td/>
<td align="char" valign="top" char=".">0.002</td>
<td align="char" valign="top" char=".">0.000</td>
<td align="char" valign="top" char=".">0.013</td>
<td align="char" valign="top" char=".">0.023</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="sec20" sec-type="discussions">
<title>4. Discussion</title>
<p>This study aimed to assess adult Indonesians&#x2019; knowledge regarding COVID-19 and COVID-19 booster vaccinations. It found that 94.8% of Malang&#x2019;s adult population had received at least one dose of COVID-19 vaccine and 88.5% had received at least three doses. These proportions are higher than the national COVID-19 vaccine and booster vaccine uptake. According to the Indonesian Ministry of Health database, the proportion of the population having received at least one dose and at least three doses of COVID-19 vaccine on 18 March 2023 were 86 and 57%, respectively (<xref ref-type="bibr" rid="ref24">24</xref>). The proportion of individuals in Malang district having received a COVID-19 vaccine booster was also higher than that reported in other countries, including the US (44%), Malaysia (49%), China (57%) (<xref ref-type="bibr" rid="ref36">36</xref>), and Saudi Arabia (22%) (<xref ref-type="bibr" rid="ref37">37</xref>).</p>
<p>Our study shows that the level of respondents&#x2019; knowledge regarding COVID-19 is relatively high in Malang. Malang residents&#x2019; scores were higher than those in prior studies using similar instruments in South Korea and China (<xref ref-type="bibr" rid="ref31">31</xref>). The regression results show that knowledge scores varied according to age, educational level, income, and employment status, indicating knowledge gaps based on age and socioeconomic status. These results support prior studies showing that members of vulnerable and less affluent groups such as older people, less educated people, people with lower incomes, and unemployed people have less access to information related to COVID-19 (<xref ref-type="bibr" rid="ref38">38</xref>). Moreover, gender was not related to respondents&#x2019; level of knowledge about COVID-19. This finding contrasts with prior studies, many of which show gender gaps in healthcare access with females being disadvantaged compared to males (<xref ref-type="bibr" rid="ref39">39</xref>). The null findings in this study may reflect similarity in COVID-19 healthcare information-seeking behavior and access to health information as most villagers had the same access to information sources.</p>
<p>Our main results show that higher COVID-19 knowledge scores were associated with higher odds of having received both initial doses of COVID-19 vaccine (OR&#x2009;=&#x2009;1.528, 95% CI&#x2009;=&#x2009;1.428&#x2013;1.634) and booster vaccinations (OR&#x2009;=&#x2009;1.260, 95% CI&#x2009;=&#x2009;1.196&#x2013;1.328). These results confirmed the hypothesis that individuals who have more accurate knowledge regarding COVID-19 are more willing to be vaccinated and are therefore more likely to receive vaccination. The findings support health literacy literature highlighting the key role of individuals&#x2019; health knowledge and the importance of information as the foundation of the intention to perform health-related behaviors (<xref ref-type="bibr" rid="ref8">8</xref>). More specifically, people who have more accurate knowledge about COVID-19 can better understand its health risks, signs, and symptoms as well as the benefits of preventive actions; they also tend to have healthier lifestyles (<xref ref-type="bibr" rid="ref8">8</xref>). People with less knowledge are more likely to have knowledge deficits about the disease and are therefore less likely to receive vaccination (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>Our analyses of the mediating variable also show that willingness to receive vaccination mediates the relationship of knowledge to vaccine uptake. These results support other findings that report the benefits of knowledge regarding COVID-19 vaccination as related to willingness to receive vaccination (<xref ref-type="bibr" rid="ref3">3</xref>). These studies also highlight that people who have sufficient knowledge about a particular vaccine can better understand its potential benefits and importance, which would further shape positive beliefs about the vaccine and strengthen trust in vaccination (<xref ref-type="bibr" rid="ref7">7</xref>). As such, people with sufficient knowledge do not perceive vaccination as a risky behavior (<xref ref-type="bibr" rid="ref40">40</xref>). In contrast, those with a lower level of knowledge are more likely to connect vaccines with adverse events and to internalize misinformation about the safety of vaccines, which might increase perceived risk of vaccine side effects (<xref ref-type="bibr" rid="ref8">8</xref>). Moreover, as one facet of individuals&#x2019; health literacy, knowledge about specific health issues can be viewed as a prerequisite for healthy decision-making, including vaccine uptake (<xref ref-type="bibr" rid="ref41">41</xref>).</p>
<p>This study further found female gender and older age to be related to lower odds of COVID-19 vaccination and booster vaccination uptake. The finding of the effect of gender on COVID-19 vaccine uptake supports prior studies showing that males are less likely to report COVID-19 vaccine hesitancy and more likely to receive COVID-19 vaccination than females (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref43">43</xref>). Females in China and US have been reported to have limited knowledge regarding the link between COVID-19 vaccination and issues such as pregnancy, fertility, and breastfeeding (<xref ref-type="bibr" rid="ref44">44</xref>, <xref ref-type="bibr" rid="ref45">45</xref>). In addition, males with COVID-19 infections are more likely to be admitted to intensive care unit admission and have higher COVID-19 mortality than females (<xref ref-type="bibr" rid="ref46">46</xref>). In the present study, higher levels of educational attainment, higher income, and being employed were associated with higher odds of receiving COVID-19 booster vaccination. These findings support prior studies showing the positive association between higher socioeconomic status and the probability of COVID-19 vaccination uptake (<xref ref-type="bibr" rid="ref47">47</xref>). Among the plausible explanations for this association are that individuals with higher educational levels and incomes may have more trust in biomedical research and government and that they may be more likely to be able to get the logistics regarding vaccine uptake.</p>
<p>The presence of comorbidities, including hypertension, cardiovascular diseases, diabetes, stroke, kidney failure, chronic obstructive pulmonary disease, cancer, and gastritis, was associated with lower vaccination uptake. Prior studies in high-income countries, including the UK and the US (<xref ref-type="bibr" rid="ref48">48</xref>), have shown higher proportions of COVID-19 vaccine uptake among adults with comorbidities than among healthy individuals. Higher COVID-19 vaccine coverage among people with comorbidities in the UK might be explained by the fact that the UK used risk-based scheduling that prioritized people with comorbidities, e.g., hypertension and type 2 diabetes, for early vaccination (<xref ref-type="bibr" rid="ref49">49</xref>). A study in China found that only 25.1% of people with diabetes mellitus received COVID-19 vaccination and this proportion was far below the rate in the general population (88%) (<xref ref-type="bibr" rid="ref50">50</xref>). Furthermore, hospitalized patients with diabetes mellitus and chronic complications had a lower COVID-19 vaccine coverage (11.2%) than those without chronic complications (43.2%). Lack of awareness of the link between chronic complications of diabetes mellitus and the risk and severity of COVID-19 is among the reasons for that low coverage. Another reason is that patients with chronic diabetes mellitus complications were more concerned about the efficacy and safety of COVID-19 vaccination.</p>
<p>People with comorbidities are at greater risk of developing severe COVID-19. Studies have highlighted the importance of COVID-19 boosters among people with comorbidities as comorbidities are among the risk factors for hyporesponsiveness and nondurable response to COVID-19 vaccination (<xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>). The lower COVID-19 booster uptake found in this study among people with comorbidities may be due to the limited availability of data on vaccine safety and efficacy, but noting the increased mortality risk among patients with comorbidities leads to conflicting attitudes toward COVID-19 vaccines. A study using an internet-based survey reported that 1 in 5 respondents with comorbidities were hesitant to receive COVID-19 vaccination (<xref ref-type="bibr" rid="ref53">53</xref>). Approximately 42% of adults reporting vaccine hesitancy in Central Java, Indonesia stated that having a comorbidity was the reason for their COVID-19 vaccine hesitancy (<xref ref-type="bibr" rid="ref54">54</xref>). The Indonesian Ministry of Health regulates the provision of COVID-19 vaccine for older people and people with comorbidities and has listed the conditions in which the vaccine cannot be administered to patients (<xref ref-type="bibr" rid="ref55">55</xref>). This regulation is not accompanied by a good information source for the general population. This is cause for great concern given that individuals with cancer and other serious comorbidities have an increased risk of mortality if they contact COVID-19. Information on vaccine efficacy and safety is related to higher acceptance. Providing health-related social media forums that rapidly disseminate accurate information about COVID-19 vaccination, especially for high-risk populations, may play an important role in increasing vaccine uptake.</p>
<sec id="sec21">
<title>4.1. Limitations</title>
<p>Several limitations of this study should be acknowledged. First, the analysis used average knowledge scores, so the specific effects of accurate responses to each individual item were not examined. Second, this study did not extensively explore other attitudinal factors associated with COVID-19 behaviors, such as perceived barriers or other communication factors including information seeking, media usage, and information processing, that may have influenced public knowledge. Third, some of the variables in this study were based on retrospective data, especially regarding respondents&#x2019; vaccination uptake and respondents&#x2019; histories of comorbidities. These data were thus subject to recall bias. Researchers conducting further studies may wish to use medical record data collected from primary healthcare centers or hospitals to address the issue of recall bias.</p>
</sec>
<sec id="sec22">
<title>4.2. Implications</title>
<p>This study has important implications for policymakers and health practitioners with valuable insights into how to create an effective strategy to increase COVID-19 vaccination uptake in the district and LMICs with similar health contexts. First, improving knowledge of the vaccine itself, including its efficacy and safety, is not enough to improve COVID-19 vaccine and booster vaccine uptake. Policymakers and health practitioners need to improve public knowledge of COVID-19 in general by acknowledging and discussing their concerns about the disease. Although most of the extant literature has focused on knowledge specifically related to COVID-19 vaccines to improve coverage (<xref ref-type="bibr" rid="ref55">55</xref>), some studies have highlighted the importance of knowledge about and positive attitudes toward the disease itself in increasing vaccine acceptance (<xref ref-type="bibr" rid="ref56 ref57 ref58">56&#x2013;58</xref>). To tackle vaccine hesitancy and increase uptake, policymakers in Indonesia and other LMICs thus need to design strategies to deliver accurate information not only regarding COVID-19 vaccines but also regarding the disease in general. Furthermore, rumors and misconceptions about COVID-19 and COVID-19 vaccines, especially on social media, should be dismissed and people should be exposed to scientific facts to improve COVID-19 vaccine uptake.</p>
<p>Second, our study shows heterogeneity in COVID-19 vaccine uptake across demographics and socioeconomic characteristics; older people, those with lower levels of educational attainment, those with lower incomes, and those who were unemployed had lower vaccine uptake than others. However, knowledge of COVID-19 and COVID-19 vaccines is lower among individuals with lower socioeconomic status, and providing information to these individuals is more challenging due to limited public health and healthcare services and other infrastructural issues such as the digital divide (<xref ref-type="bibr" rid="ref58 ref59 ref60 ref61">58&#x2013;61</xref>). Despite improving accessibility of vaccination programs to those specific socioeconomic groups, introducing more public health strategies to deliver accurate information is thus important to address communication inequalities and design public health communications that will more effectively reduce the existing disparities across segments of the population.</p>
<p>Finally, our findings have important implications for the rollout of booster vaccines. Despite robust immune responses after two doses of COVID-19 vaccine, comorbidities are strongly associated with hyporesponsiveness to COVID-19 vaccination. Booster vaccination is thus required to maintain high levels of protective antibodies in individuals with comorbidities. Our findings showing lower booster uptake among people with comorbidities suggest that interventions to improve access and health literacy need to be provided for these individuals in particular.</p>
</sec>
<sec id="sec23">
<title>4.3. Conclusion</title>
<p>In conclusion, this study found significant positive associations between COVID-19 knowledge and vaccine uptake. Our findings suggest that interventions and public health programs aiming to improve knowledge, attitudes, and perceptions regarding COVID-19 vaccination can be implemented to improve vaccine uptake. Furthermore, our findings may contribute to developing a strategy for controlling the COVID-19 pandemic by addressing other determinants of vaccination uptake, including age, gender, and socioeconomic status.</p>
</sec>
</sec>
<sec id="sec24" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="sec25">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Brawijaya University Ethical Board (Reference: 11/EC/KEPK/04/2021). The participants provided their written informed consent to participate in this study. Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin.</p>
</sec>
<sec id="sec26">
<title>Author contributions</title>
<p>SS and AM prepared the study design, collected data, conducted data analyses, and reviewed the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec27" sec-type="funding-information">
<title>Funding</title>
<p>This study was funded by the Endowment Fund for Education (LPDP), Ministry of Finance, Indonesia, based on Decision Letter Number KEP-43/LPDP/2019 dated June 26, 2019; Decision Letter Number KEP-20/LPDP/2021 dated March 10, 2021; Cooperative Agreement to participate in the International Collaboration-Productive Open Call Research Funding scheme, based on Number PRJ-71/LPDP/2021 dated April 14, 2021, and Number: 01/DIPI/2021 dated April 14, 2021, for Research Grant Number RISPRO/KI/B1/TKL/5/15129/1/2020.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>The authors thank the Endowment Fund for Education (LPDP), the Indonesian Ministry of Finance, and the Indonesian Science Fund, which provided independent scientific research funding for the investigators to perform this research. The authors also thank all respondents who participated in the study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Machingaidze</surname><given-names>S</given-names></name> <name><surname>Wiysonge</surname><given-names>CS</given-names></name></person-group>. <article-title>Understanding COVID-19 vaccine hesitancy</article-title>. <source>Nat Med</source>. (<year>2021</year>) <volume>27</volume>:<fpage>1338</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41591-021-01459-7</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>LE</given-names></name> <name><surname>Aml&#x00F4;t</surname><given-names>R</given-names></name> <name><surname>Weinman</surname><given-names>J</given-names></name> <name><surname>Yiend</surname><given-names>J</given-names></name> <name><surname>Rubin</surname><given-names>GJ</given-names></name></person-group>. <article-title>A systematic review of factors affecting vaccine uptake in young children</article-title>. <source>Vaccine</source>. (<year>2017</year>) <volume>35</volume>:<fpage>6059</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.09.046</pub-id>, PMID: <pub-id pub-id-type="pmid">28974409</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neely</surname><given-names>SR</given-names></name> <name><surname>Eldredge</surname><given-names>C</given-names></name> <name><surname>Ersing</surname><given-names>R</given-names></name> <name><surname>Remington</surname><given-names>C</given-names></name></person-group>. <article-title>Vaccine hesitancy and exposure to misinformation: a survey analysis</article-title>. <source>J Gen Intern Med</source>. (<year>2022</year>) <volume>37</volume>:<fpage>179</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11606-021-07171-z</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahiakpa</surname><given-names>JK</given-names></name> <name><surname>Cosmas</surname><given-names>NT</given-names></name> <name><surname>Anyiam</surname><given-names>FE</given-names></name> <name><surname>Enalume</surname><given-names>KO</given-names></name> <name><surname>Lawan</surname><given-names>I</given-names></name> <name><surname>Gabriel</surname><given-names>IB</given-names></name> <etal/></person-group>. <article-title>COVID-19 vaccines uptake: public knowledge, awareness, perception and acceptance among adult Africans</article-title>. <source>PLoS One</source>. (<year>2022</year>) <volume>17</volume>:<fpage>e0268230</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0268230</pub-id>, PMID: <pub-id pub-id-type="pmid">35648745</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>A</given-names></name> <name><surname>Montelpare</surname><given-names>WJ</given-names></name></person-group>. <article-title>Predictors of vaccine hesitancy: implications for COVID-19 public health messaging</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>18</volume>:<fpage>8054</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph18158054</pub-id>, PMID: <pub-id pub-id-type="pmid">34360345</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okan</surname><given-names>O</given-names></name> <name><surname>Messer</surname><given-names>M</given-names></name> <name><surname>Levin-Zamir</surname><given-names>D</given-names></name> <name><surname>Paakkari</surname><given-names>L</given-names></name> <name><surname>S&#x00F8;rensen</surname><given-names>K</given-names></name></person-group>. <article-title>Health literacy as a social vaccine in the COVID-19 pandemic</article-title>. <source>Health Promot Int</source>. (<year>2022</year>) <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1093/heapro/daab197</pub-id>, PMID: <pub-id pub-id-type="pmid">35022721</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name> <name><surname>Jiang</surname><given-names>S</given-names></name> <name><surname>Wu</surname><given-names>Q</given-names></name></person-group>. <article-title>Factors influencing COVID-19 vaccination intention: the roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication</article-title>. <source>Patient Educ Couns</source>. (<year>2022</year>) <volume>105</volume>:<fpage>277</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pec.2021.09.023</pub-id>, PMID: <pub-id pub-id-type="pmid">34565643</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>LMS</given-names></name> <name><surname>Gee</surname><given-names>PM</given-names></name> <name><surname>Katz</surname><given-names>RA</given-names></name></person-group>. <article-title>The importance of understanding COVID-19: the role of knowledge in promoting adherence to protective behaviors</article-title>. <source>Front Public Health</source>. (<year>2021</year>) <volume>9</volume>:<fpage>581497</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2021.581497</pub-id>, PMID: <pub-id pub-id-type="pmid">33889557</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Klahr</surname><given-names>D</given-names></name> <name><surname>Kotovsky</surname><given-names>K</given-names></name></person-group>. <source>Complex information processing: The impact of Herbert a. Simon</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Psychology Press</publisher-name> (<year>2013</year>).</citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suen</surname><given-names>LK</given-names></name> <name><surname>So</surname><given-names>ZYY</given-names></name> <name><surname>Yeung</surname><given-names>SKW</given-names></name> <name><surname>Lo</surname><given-names>KYK</given-names></name> <name><surname>Lam</surname><given-names>SC</given-names></name></person-group>. <article-title>Epidemiological investigation on hand hygiene knowledge and behaviour: a cross-sectional study on gender disparity</article-title>. <source>BMC Public Health</source>. (<year>2019</year>) <volume>19</volume>:<fpage>401</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-019-6705-5</pub-id>, PMID: <pub-id pub-id-type="pmid">30975130</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bults</surname><given-names>M</given-names></name> <name><surname>Beaujean</surname><given-names>DJMA</given-names></name> <name><surname>Richardus</surname><given-names>JH</given-names></name> <name><surname>Voeten</surname><given-names>HACM</given-names></name></person-group>. <article-title>Perceptions and behavioral responses of the general public during the 2009 influenza a (H1N1) pandemic: a systematic review</article-title>. <source>Disaster Med Public Health Prep</source>. (<year>2015</year>) <volume>9</volume>:<fpage>207</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1017/dmp.2014.160</pub-id>, PMID: <pub-id pub-id-type="pmid">25882127</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zickfeld</surname><given-names>JH</given-names></name> <name><surname>Schubert</surname><given-names>TW</given-names></name> <name><surname>Herting</surname><given-names>AK</given-names></name> <name><surname>Grahe</surname><given-names>J</given-names></name> <name><surname>Faasse</surname><given-names>K</given-names></name></person-group>. <article-title>Correlates of health-protective behavior during the initial days of the COVID-19 outbreak in Norway</article-title>. <source>Front Psychol</source>. (<year>2020</year>) <volume>11</volume>:<fpage>564083</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyg.2020.564083</pub-id>, PMID: <pub-id pub-id-type="pmid">33123045</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moreland</surname><given-names>A</given-names></name> <name><surname>Herlihy</surname><given-names>C</given-names></name> <name><surname>Tynan</surname><given-names>MA</given-names></name> <name><surname>Sunshine</surname><given-names>G</given-names></name> <name><surname>McCord</surname><given-names>RF</given-names></name> <name><surname>Hilton</surname><given-names>C</given-names></name> <etal/></person-group>. <article-title>Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement&#x2014;United States, March 1&#x2013;May 31, 2020</article-title>. <source>Morb Mortal Wkly Rep</source>. (<year>2020</year>) <volume>69</volume>:<fpage>1198</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm6935a2</pub-id>, PMID: <pub-id pub-id-type="pmid">32881851</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clements</surname><given-names>JM</given-names></name></person-group>. <article-title>Knowledge and behaviors toward COVID-19 among US residents during the early days of the pandemic: cross-sectional online questionnaire</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2020</year>) <volume>6</volume>:<fpage>e19161</fpage>. doi: <pub-id pub-id-type="doi">10.2196/19161</pub-id>, PMID: <pub-id pub-id-type="pmid">32369759</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mutombo</surname><given-names>PN</given-names></name> <name><surname>Fallah</surname><given-names>MP</given-names></name> <name><surname>Munodawafa</surname><given-names>D</given-names></name> <name><surname>Kabel</surname><given-names>A</given-names></name> <name><surname>Houeto</surname><given-names>D</given-names></name> <name><surname>Goronga</surname><given-names>T</given-names></name> <etal/></person-group>. <article-title>COVID-19 vaccine hesitancy in Africa: a call to action</article-title>. <source>Lancet Glob Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>e320</fpage>&#x2013;<lpage>1</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(21)00563-5</pub-id>, PMID: <pub-id pub-id-type="pmid">34942117</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simas</surname><given-names>C</given-names></name> <name><surname>Larson</surname><given-names>HJ</given-names></name></person-group>. <article-title>Overcoming vaccine hesitancy in low-income and middle-income regions</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2021</year>) <volume>7</volume>:<fpage>41</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41572-021-00279-w</pub-id>, PMID: <pub-id pub-id-type="pmid">34112811</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>S</given-names></name> <name><surname>Hirsch</surname><given-names>JS</given-names></name> <name><surname>Narasimhan</surname><given-names>M</given-names></name> <name><surname>Crawford</surname><given-names>JM</given-names></name> <name><surname>McGinn</surname><given-names>T</given-names></name> <name><surname>Davidson</surname><given-names>KW</given-names></name> <etal/></person-group>. <article-title>Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area</article-title>. <source>JAMA</source>. (<year>2020</year>) <volume>323</volume>:<fpage>2052</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.6775</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>LC</given-names></name> <name><surname>Parodi</surname><given-names>SM</given-names></name> <name><surname>Escobar</surname><given-names>GJ</given-names></name> <name><surname>Liu</surname><given-names>VX</given-names></name></person-group>. <article-title>Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California</article-title>. <source>JAMA</source>. (<year>2020</year>) <volume>323</volume>:<fpage>2195</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.7202</pub-id>, PMID: <pub-id pub-id-type="pmid">32329797</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohseni</surname><given-names>H</given-names></name> <name><surname>Kiran</surname><given-names>A</given-names></name> <name><surname>Khorshidi</surname><given-names>R</given-names></name> <name><surname>Rahimi</surname><given-names>K</given-names></name></person-group>. <article-title>Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study</article-title>. <source>Eur Heart J</source>. (<year>2017</year>) <volume>38</volume>:<fpage>326</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1093/eurheartj/ehw411</pub-id>, PMID: <pub-id pub-id-type="pmid">27660378</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallone</surname><given-names>MS</given-names></name> <name><surname>Infantino</surname><given-names>V</given-names></name> <name><surname>Ferorelli</surname><given-names>D</given-names></name> <name><surname>Stefanizzi</surname><given-names>P</given-names></name> <name><surname>de Nitto</surname><given-names>S</given-names></name> <name><surname>Tafuri</surname><given-names>S</given-names></name></person-group>. <article-title>Vaccination coverage in patients affected by chronic diseases: a 2014 cross-sectional study among subjects hospitalized at Bari Policlinico General Hospital</article-title>. <source>Am J Infect Control</source>. (<year>2018</year>) <volume>46</volume>:<fpage>e9</fpage>&#x2013;<lpage>e11</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajic.2017.10.004</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>N</given-names></name> <name><surname>Gu</surname><given-names>P</given-names></name> <name><surname>Sun</surname><given-names>X</given-names></name> <name><surname>Han</surname><given-names>H</given-names></name> <name><surname>Liu</surname><given-names>W</given-names></name> <name><surname>Song</surname><given-names>N</given-names></name> <etal/></person-group>. <article-title>Acceptance of COVID-19 vaccines in patients with chronic diseases: a cross-sectional study</article-title>. <source>J Clin Nurs</source>. (<year>2022</year>) <volume>31</volume>:<fpage>3286</fpage>&#x2013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jocn.16284</pub-id>, PMID: <pub-id pub-id-type="pmid">35285111</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name> <name><surname>du</surname><given-names>J</given-names></name> <name><surname>Li</surname><given-names>Z</given-names></name> <name><surname>Xu</surname><given-names>Z</given-names></name> <name><surname>Wu</surname><given-names>Y</given-names></name> <name><surname>Duan</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>It is time to improve the acceptance of COVID-19 vaccines among people with chronic diseases: a systematic review and meta-analysis</article-title>. <source>J Med Virol</source>. (<year>2023</year>) <volume>95</volume>:<fpage>e28509</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jmv.28509</pub-id>, PMID: <pub-id pub-id-type="pmid">36655758</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="book"><person-group person-group-type="author"><collab id="coll1">Indonesian Ministry of Health</collab></person-group>. <source>National COVID-19 Vaccine Coverage</source>. <publisher-loc>Jakarta</publisher-loc>: <publisher-name>Indonesian Ministry of Health</publisher-name> (<year>2023</year>).</citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="book"><person-group person-group-type="author"><collab id="coll2">Malang District Health Office</collab></person-group>. <source>Malang COVID-19 vaccine coverage</source>. <publisher-loc>Malang</publisher-loc>: <publisher-name>Malang District Health Office</publisher-name> (<year>2023</year>).</citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="book"><person-group person-group-type="author"><collab id="coll3">Malang District Government</collab></person-group>. <source>Malang statistic year report 2022</source>. <publisher-loc>Malang</publisher-loc>: <publisher-name>Malang District Government</publisher-name> (<year>2023</year>).</citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakshminarasimhappa</surname><given-names>M</given-names></name></person-group>. <article-title>Web-based and smart mobile app for data collection: kobo toolbox/kobo collect</article-title>. <source>J. Indian Lib. Assoc.</source> (<year>2022</year>) <volume>57</volume>:<fpage>72</fpage>&#x2013;<lpage>9</lpage>.</citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rikitu Terefa</surname><given-names>D</given-names></name> <name><surname>Shama</surname><given-names>AT</given-names></name> <name><surname>Feyisa</surname><given-names>BR</given-names></name> <name><surname>Desisa</surname><given-names>AE</given-names></name> <name><surname>Geta</surname><given-names>ET</given-names></name> <name><surname>Cheme</surname><given-names>MC</given-names></name> <etal/></person-group>. <article-title>COVID-19 vaccine uptake and associated factors among health professionals in Ethiopia</article-title>. <source>Infect. Drug Resist.</source> (<year>2021</year>) <volume>14</volume>:<fpage>5531</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S344647</pub-id>, PMID: <pub-id pub-id-type="pmid">34984008</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>S</given-names></name> <name><surname>Zang</surname><given-names>S</given-names></name> <name><surname>Gong</surname><given-names>L</given-names></name> <name><surname>Xu</surname><given-names>C</given-names></name> <name><surname>Lin</surname><given-names>L</given-names></name> <name><surname>Francis</surname><given-names>MR</given-names></name> <etal/></person-group>. <article-title>Willingness and uptake of the COVID-19 testing and vaccination in urban China during the low-risk period: a cross-sectional study</article-title>. <source>BMC Public Health</source>. (<year>2022</year>) <volume>22</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-022-12969-5</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LH</given-names></name> <name><surname>Joshi</surname><given-names>AD</given-names></name> <name><surname>Drew</surname><given-names>DA</given-names></name> <name><surname>Merino</surname><given-names>J</given-names></name> <name><surname>Ma</surname><given-names>W</given-names></name> <name><surname>Lo</surname><given-names>CH</given-names></name> <etal/></person-group>. <article-title>Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom</article-title>. <source>Nat Commun</source>. (<year>2022</year>) <volume>13</volume>:<fpage>636</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-28200-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35105869</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>B-L</given-names></name> <name><surname>Luo</surname><given-names>W</given-names></name> <name><surname>Li</surname><given-names>HM</given-names></name> <name><surname>Zhang</surname><given-names>QQ</given-names></name> <name><surname>Liu</surname><given-names>XG</given-names></name> <name><surname>Li</surname><given-names>WT</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey</article-title>. <source>Int J Biol Sci</source>. (<year>2020</year>) <volume>16</volume>:<fpage>1745</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.7150/ijbs.45221</pub-id>, PMID: <pub-id pub-id-type="pmid">32226294</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name> <name><surname>Kang</surname><given-names>B-A</given-names></name> <name><surname>You</surname><given-names>M</given-names></name></person-group>. <article-title>Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea</article-title>. <source>BMC Public Health</source>. (<year>2021</year>) <volume>21</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-021-10285-y</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qutob</surname><given-names>N</given-names></name> <name><surname>Awartani</surname><given-names>F</given-names></name></person-group>. <article-title>Knowledge, attitudes and practices (KAP) towards COVID-19 among Palestinians during the COVID-19 outbreak: a cross-sectional survey</article-title>. <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0244925</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0244925</pub-id>, PMID: <pub-id pub-id-type="pmid">33400722</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adab</surname><given-names>P</given-names></name> <name><surname>Haroon</surname><given-names>S</given-names></name> <name><surname>O&#x2019;Hara</surname><given-names>ME</given-names></name> <name><surname>Jordan</surname><given-names>RE</given-names></name></person-group>. <article-title>Comorbidities and COVID-19</article-title>. <source>BMJ</source>. (<year>2022</year>). doi: <pub-id pub-id-type="doi">10.1136/bmj.o1431</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sujarwoto</surname><given-names>S</given-names></name> <name><surname>Holipah</surname><given-names>H</given-names></name> <name><surname>Maharani</surname><given-names>A</given-names></name></person-group>. <article-title>A cross-sectional study of knowledge, attitudes, and practices concerning COVID-19 outbreaks in the general population in Malang District, Indonesia</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2022</year>) <volume>19</volume>:<fpage>4287</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph19074287</pub-id>, PMID: <pub-id pub-id-type="pmid">35409968</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Menard</surname><given-names>S</given-names></name></person-group>. <source>Applied logistic regression analysis</source>. <publisher-loc>Thousand Oaks, CA</publisher-loc>: <publisher-name>Sage</publisher-name> (<year>2002</year>).</citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>A</given-names></name> <name><surname>Coiado</surname><given-names>OC</given-names></name></person-group>. <article-title>COVID-19 vaccine and booster hesitation around the world: a literature review</article-title>. <source>Front Med</source>. (<year>2023</year>) <volume>9</volume>:<fpage>3994</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2022.1054557</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alshahrani</surname><given-names>NZ</given-names></name> <name><surname>Alsabaani</surname><given-names>AA</given-names></name> <name><surname>Ridda</surname><given-names>I</given-names></name> <name><surname>Rashid</surname><given-names>H</given-names></name> <name><surname>Alzahrani</surname><given-names>F</given-names></name> <name><surname>Almutairi</surname><given-names>TH</given-names></name> <etal/></person-group>. <article-title>Uptake of COVID-19 booster dose among Saudi Arabian population</article-title>. <source>Medicina</source>. (<year>2022</year>) <volume>58</volume>:<fpage>972</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medicina58070972</pub-id>, PMID: <pub-id pub-id-type="pmid">35888690</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anjorin</surname><given-names>AA</given-names></name> <name><surname>Odetokun</surname><given-names>IA</given-names></name> <name><surname>Abioye</surname><given-names>AI</given-names></name> <name><surname>Elnadi</surname><given-names>H</given-names></name> <name><surname>Umoren</surname><given-names>MV</given-names></name> <name><surname>Damaris</surname><given-names>BF</given-names></name> <etal/></person-group>. <article-title>Will Africans take COVID-19 vaccination?</article-title> <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0260575</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0260575</pub-id>, PMID: <pub-id pub-id-type="pmid">34851998</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinchoff</surname><given-names>J</given-names></name> <name><surname>Santhya</surname><given-names>KG</given-names></name> <name><surname>White</surname><given-names>C</given-names></name> <name><surname>Rampal</surname><given-names>S</given-names></name> <name><surname>Acharya</surname><given-names>R</given-names></name> <name><surname>Ngo</surname><given-names>TD</given-names></name></person-group>. <article-title>Gender specific differences in COVID-19 knowledge, behavior and health effects among adolescents and young adults in Uttar Pradesh and Bihar, India</article-title>. <source>PLoS One</source>. (<year>2020</year>) <volume>15</volume>:<fpage>e0244053</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0244053</pub-id>, PMID: <pub-id pub-id-type="pmid">33332461</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaqub</surname><given-names>O</given-names></name> <name><surname>Castle-Clarke</surname><given-names>S</given-names></name> <name><surname>Sevdalis</surname><given-names>N</given-names></name> <name><surname>Chataway</surname><given-names>J</given-names></name></person-group>. <article-title>Attitudes to vaccination: a critical review</article-title>. <source>Soc Sci Med</source>. (<year>2014</year>) <volume>112</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.socscimed.2014.04.018</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro-S&#x00E1;nchez</surname><given-names>E</given-names></name> <name><surname>Chang</surname><given-names>PWS</given-names></name> <name><surname>Vila-Candel</surname><given-names>R</given-names></name> <name><surname>Escobedo</surname><given-names>AA</given-names></name> <name><surname>Holmes</surname><given-names>AH</given-names></name></person-group>. <article-title>Health literacy and infectious diseases: why does it matter?</article-title> <source>Int J Infect Dis</source>. (<year>2016</year>) <volume>43</volume>:<fpage>103</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijid.2015.12.019</pub-id>, PMID: <pub-id pub-id-type="pmid">26751238</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dror</surname><given-names>AA</given-names></name> <name><surname>Eisenbach</surname><given-names>N</given-names></name> <name><surname>Taiber</surname><given-names>S</given-names></name> <name><surname>Morozov</surname><given-names>NG</given-names></name> <name><surname>Mizrachi</surname><given-names>M</given-names></name> <name><surname>Zigron</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Vaccine hesitancy: the next challenge in the fight against COVID-19</article-title>. <source>Eur J Epidemiol</source>. (<year>2020</year>) <volume>35</volume>:<fpage>775</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10654-020-00671-y</pub-id>, PMID: <pub-id pub-id-type="pmid">32785815</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khubchandani</surname><given-names>J</given-names></name> <name><surname>Sharma</surname><given-names>S</given-names></name> <name><surname>Price</surname><given-names>JH</given-names></name> <name><surname>Wiblishauser</surname><given-names>MJ</given-names></name> <name><surname>Sharma</surname><given-names>M</given-names></name> <name><surname>Webb</surname><given-names>FJ</given-names></name></person-group>. <article-title>COVID-19 vaccination hesitancy in the United States: a rapid national assessment</article-title>. <source>J Community Health</source>. (<year>2021</year>) <volume>46</volume>:<fpage>270</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10900-020-00958-x</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>K.H.</given-names></name> <name><surname>Srivastav</surname><given-names>A.</given-names></name> <name><surname>Razzaghi</surname><given-names>H.</given-names></name> <name><surname>Williams</surname><given-names>W.</given-names></name> <name><surname>Lindley</surname><given-names>M.C.</given-names></name> <name><surname>Jorgensen</surname><given-names>C.</given-names></name> <etal/></person-group>. <source>COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination&#x2014;United States, September and December 2020</source>. (<year>2021</year>), <publisher-loc>Hoboken, HJ</publisher-loc>: <publisher-name>Wiley Online Library</publisher-name>, <volume>21</volume>, <fpage>1650</fpage>&#x2013;<lpage>1656</lpage>.</citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name> <name><surname>Gao</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>X</given-names></name> <name><surname>Hu</surname><given-names>Y</given-names></name> <name><surname>Yang</surname><given-names>H</given-names></name> <name><surname>Zhou</surname><given-names>YH</given-names></name></person-group>. <article-title>Real-world acceptance of COVID-19 vaccines among healthcare workers in perinatal medicine in China</article-title>. <source>Vaccine</source>. (<year>2021</year>) <volume>9</volume>:<fpage>704</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines9070704</pub-id>, PMID: <pub-id pub-id-type="pmid">34199143</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peckham</surname><given-names>H</given-names></name> <name><surname>de Gruijter</surname><given-names>NM</given-names></name> <name><surname>Raine</surname><given-names>C</given-names></name> <name><surname>Radziszewska</surname><given-names>A</given-names></name> <name><surname>Ciurtin</surname><given-names>C</given-names></name> <name><surname>Wedderburn</surname><given-names>LR</given-names></name> <etal/></person-group>. <article-title>Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>6317</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-19741-6</pub-id>, PMID: <pub-id pub-id-type="pmid">33298944</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malesza</surname><given-names>M</given-names></name> <name><surname>Bozym</surname><given-names>M</given-names></name></person-group>. <article-title>Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland</article-title>. <source>medRxiv</source>. (<year>2021</year>). doi: <pub-id pub-id-type="doi">10.1101/2021.03.21.21254047</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LH</given-names></name> <name><surname>Joshi</surname><given-names>AD</given-names></name> <name><surname>Drew</surname><given-names>DA</given-names></name> <name><surname>Merino</surname><given-names>J</given-names></name> <name><surname>Ma</surname><given-names>W</given-names></name> <name><surname>Lo</surname><given-names>C-H</given-names></name> <etal/></person-group>. <article-title>Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake</article-title>. <source>medrxiv</source>. (<year>2021</year>). doi: <pub-id pub-id-type="doi">10.1101/2021.02.25.21252402</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="book"><source>UK health security agency, coronavirus (COVID-19) vaccination programme in the UK</source>. <publisher-loc>London</publisher-loc>: <publisher-name>UK Health Security Agency</publisher-name> (<year>2020</year>).</citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name> <name><surname>Chen</surname><given-names>S</given-names></name> <name><surname>Wang</surname><given-names>Y</given-names></name> <name><surname>Duan</surname><given-names>L</given-names></name> <name><surname>Li</surname><given-names>J</given-names></name> <name><surname>Shan</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Prevalence and determinants of COVID-19 vaccination uptake were different between Chinese diabetic inpatients with and without chronic complications: a cross-sectional survey</article-title>. <source>Vaccine</source>. (<year>2022</year>) <volume>10</volume>:<fpage>994</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines10070994</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00F8;gaard</surname><given-names>OS</given-names></name> <name><surname>Reekie</surname><given-names>J</given-names></name> <name><surname>Johansen</surname><given-names>IS</given-names></name> <name><surname>Nielsen</surname><given-names>H</given-names></name> <name><surname>Benfield</surname><given-names>T</given-names></name> <name><surname>Wiese</surname><given-names>L</given-names></name> <etal/></person-group>. <article-title>Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE study</article-title>. <source>Clin Microbiol Infect</source>. (<year>2022</year>) <volume>28</volume>:<fpage>1126</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2022.03.003</pub-id>, PMID: <pub-id pub-id-type="pmid">35283313</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mallah</surname><given-names>N</given-names></name> <name><surname>Pardo-Seco</surname><given-names>J</given-names></name> <name><surname>L&#x00F3;pez-P&#x00E9;rez</surname><given-names>LR</given-names></name> <name><surname>Gonz&#x00E1;lez-P&#x00E9;rez</surname><given-names>JM</given-names></name> <name><surname>Ros&#x00F3;n</surname><given-names>B</given-names></name> <name><surname>Otero-Barr&#x00F3;s</surname><given-names>MT</given-names></name> <etal/></person-group>. <article-title>Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain</article-title>. <source>Environ Res</source>. (<year>2022</year>) <volume>215</volume>:<fpage>114252</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.envres.2022.114252</pub-id>, PMID: <pub-id pub-id-type="pmid">36096168</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>R</given-names></name> <name><surname>Hervey</surname><given-names>J</given-names></name> <name><surname>Hoffman</surname><given-names>K</given-names></name> <name><surname>Wood</surname><given-names>J</given-names></name> <name><surname>Johnson</surname><given-names>J</given-names></name> <name><surname>Deighton</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: cross-sectional, internet-based survey</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2022</year>) <volume>8</volume>:<fpage>e29872</fpage>. doi: <pub-id pub-id-type="doi">10.2196/29872</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Utami</surname><given-names>A</given-names></name> <name><surname>Margawati</surname><given-names>A</given-names></name> <name><surname>Pramono</surname><given-names>D</given-names></name> <name><surname>Nugraheni</surname><given-names>A</given-names></name> <name><surname>Pramudo</surname><given-names>S</given-names></name></person-group>. <article-title>Determinant factors of COVID-19 vaccine hesitancy among adult and elderly population in Central Java, Indonesia</article-title>. <source>Patient Prefer Adherence</source>. (<year>2022</year>) <volume>16</volume>:<fpage>1559</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.2147/PPA.S365663</pub-id>, PMID: <pub-id pub-id-type="pmid">35789823</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="book"><person-group person-group-type="author"><collab id="coll4">Ministry of Health, Republic of Indonesia</collab></person-group>. <source>Regulation number HK.02.02/I/368/2021 regarding COVID-19 vaccination on older people, people with comorbidity and COVID-19 survivals or Pelaksanaan Vaksinasi COVID-19 pada Kelompok Sasaran Lansia, Komorbid dan Penyintas COVID-19</source>. <publisher-loc>Jakarta</publisher-loc>: <publisher-name>Ministry of Health, Republic of Indonesia</publisher-name> (<year>2021</year>).</citation></ref>
<ref id="ref56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adane</surname><given-names>M</given-names></name> <name><surname>Ademas</surname><given-names>A</given-names></name> <name><surname>Kloos</surname><given-names>H</given-names></name></person-group>. <article-title>Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia</article-title>. <source>BMC Public Health</source>. (<year>2022</year>) <volume>22</volume>:<fpage>128</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-021-12362-8</pub-id>, PMID: <pub-id pub-id-type="pmid">35042476</pub-id></citation></ref>
<ref id="ref57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahmud</surname><given-names>S</given-names></name> <name><surname>Mohsin</surname><given-names>M</given-names></name> <name><surname>Khan</surname><given-names>IA</given-names></name> <name><surname>Mian</surname><given-names>AU</given-names></name> <name><surname>Zaman</surname><given-names>MA</given-names></name></person-group>. <article-title>Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh</article-title>. <source>PLoS One</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0257096</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0257096</pub-id>, PMID: <pub-id pub-id-type="pmid">34499673</pub-id></citation></ref>
<ref id="ref58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trucchi</surname><given-names>C</given-names></name> <name><surname>Costantino</surname><given-names>C</given-names></name> <name><surname>Restivo</surname><given-names>V</given-names></name> <name><surname>Bertoncello</surname><given-names>C</given-names></name> <name><surname>Fortunato</surname><given-names>F</given-names></name> <name><surname>Tafuri</surname><given-names>S</given-names></name> <etal/></person-group>. <article-title>Immunization campaigns and strategies against human papillomavirus in Italy: the results of a survey to regional and local health units representatives</article-title>. <source>Biomed Res Int</source>. (<year>2019</year>) <volume>2019</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2019/6764154</pub-id>, PMID: <pub-id pub-id-type="pmid">31355274</pub-id></citation></ref>
<ref id="ref59"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammour</surname><given-names>KA</given-names></name> <name><surname>Farha</surname><given-names>RA</given-names></name> <name><surname>Manaseer</surname><given-names>Q</given-names></name> <name><surname>Al-Manaseer</surname><given-names>B</given-names></name></person-group>. <article-title>Factors affecting the public&#x2019;s knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated</article-title>. <source>J Am Pharm Assoc</source>. (<year>2022</year>) <volume>62</volume>:<fpage>309</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.japh.2021.06.021</pub-id>, PMID: <pub-id pub-id-type="pmid">34301497</pub-id></citation></ref>
<ref id="ref60"><label>60.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bono</surname><given-names>SA</given-names></name> <name><surname>Faria de Moura Villela</surname><given-names>E</given-names></name> <name><surname>Siau</surname><given-names>CS</given-names></name> <name><surname>Chen</surname><given-names>WS</given-names></name> <name><surname>Pengpid</surname><given-names>S</given-names></name> <name><surname>Hasan</surname><given-names>MT</given-names></name> <etal/></person-group>. <article-title>Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries</article-title>. <source>Vaccine</source>. (<year>2021</year>) <volume>9</volume>:<fpage>515</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines9050515</pub-id>, PMID: <pub-id pub-id-type="pmid">34067682</pub-id></citation></ref>
<ref id="ref61"><label>61.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sujarwoto</surname><given-names>S</given-names></name> <name><surname>Maharani</surname><given-names>A</given-names></name></person-group>. <article-title>Sociodemographic characteristics and health access associated with COVID-19 infection and death: a cross-sectional study in Malang District, Indonesia</article-title>. <source>BMJ Open</source>. (<year>2022</year>) <volume>12</volume>:<fpage>e052042</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2021-052042</pub-id>, PMID: <pub-id pub-id-type="pmid">35613769</pub-id></citation></ref>
</ref-list>
</back>
</article>